US20020077593A1 - Apparatus and method for isolated lung access - Google Patents

Apparatus and method for isolated lung access Download PDF

Info

Publication number
US20020077593A1
US20020077593A1 US10/074,861 US7486102A US2002077593A1 US 20020077593 A1 US20020077593 A1 US 20020077593A1 US 7486102 A US7486102 A US 7486102A US 2002077593 A1 US2002077593 A1 US 2002077593A1
Authority
US
United States
Prior art keywords
catheter
isolation
lumen
inner catheter
distal end
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/074,861
Inventor
Rodney Perkins
Peter Soltesz
Robert Kotmel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pulmonx Corp
Original Assignee
Pulmonx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/425,272 priority Critical patent/US6398775B1/en
Priority to PCT/US2000/029417 priority patent/WO2003105941A1/en
Application filed by Pulmonx Corp filed Critical Pulmonx Corp
Priority to US10/074,861 priority patent/US20020077593A1/en
Publication of US20020077593A1 publication Critical patent/US20020077593A1/en
Assigned to PULMONX reassignment PULMONX ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KOTMEL, ROBERT, PERKINS, RODNEY A., SOLTESZ, PETER P.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M25/003Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71Suction drainage systems
    • A61M1/77Suction-irrigation systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84Drainage tubes; Aspiration tips
    • A61M1/85Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0402Special features for tracheal tubes not otherwise provided for
    • A61M16/0404Special features for tracheal tubes not otherwise provided for with means for selective or partial lung respiration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0434Cuffs
    • A61M16/0454Redundant cuffs
    • A61M16/0459Redundant cuffs one cuff behind another
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0463Tracheal tubes combined with suction tubes, catheters or the like; Outside connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0475Tracheal tubes having openings in the tube
    • A61M16/0477Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids
    • A61M16/0479Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids above the cuff, e.g. giving access to the upper trachea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0475Tracheal tubes having openings in the tube
    • A61M16/0477Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids
    • A61M16/0484Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids at the distal end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0486Multi-lumen tracheal tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06Body-piercing guide needles or the like
    • A61M25/0662Guide tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0034Multi-lumen catheters with stationary elements characterized by elements which are assembled, connected or fused, e.g. splittable tubes, outer sheaths creating lumina or separate cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0036Multi-lumen catheters with stationary elements with more than four lumina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1052Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/587Lighting arrangements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1025Respiratory system
    • A61M2210/1039Lungs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M25/0032Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts

Definitions

  • the present invention relates generally to medical apparatus, systems, methods, and kits. More particularly, the present invention relates to methods and apparatus for isolating sub-bronchial regions of the lung and delivering or retrieving substances from such isolated regions.
  • Lung access and isolation is of interest in numerous therapeutic and diagnostic medical procedures.
  • access to the lungs is useful for both local and systemic drug delivery, lung lavage, visual assessment and diagnosis of lung function, and the like.
  • an endotracheal or tracheostomy tube having an inflatable cuff at its distal end may be placed in a patient's trachea and used to deliver a drug aerosol to the whole of the lungs. While this can improve the efficiency of drug delivery (reducing the amount of drug deposited in the nasal passages or throat), it helps little in targeting treatment within any particular region of the lungs. Thus, it has been further proposed to use a secondary catheter placed through an endotracheal or tracheostomy tube for selectively isolating the left or right bronchus.
  • the secondary catheter can have an inflatable cuff which is positioned immediately beyond the main branching between the left and right bronchi.
  • One of the bronchi can then be accessed through the secondary catheter while the other is accessed through the tracheal tube.
  • Such systems are described, for example, in U.S. Pat. Nos. 5,285,778 and 5,660,175. While such systems offer significant benefits over the use of an endotracheal tube by itself, they still do not permit isolation of sub-bronchial regions of the lung for drug delivery, lavage, or any other purpose.
  • a system for bronchoalveolar lavage which can isolate a sub-bronchial region of the lung is described in published Application No. WO 92/10971.
  • a co-axial catheter system is placed through an endotracheal tube, with the inner most catheter having an isolation wedge or balloon which can be positioned in a remote bronchiole to effect isolation of a distal region of the lung.
  • the outer catheter has no capability for isolating the lung and is used, for example, for ventilating the lung proximal to the isolation cuff. While potentially an improvement over prior systems, the apparatus of WO 92/10971 will be very difficult to position, making targeting of particular sub-bronchial regions very difficult.
  • the inability to isolate a bronchus upstream from the distal isolation cuff limits the ability to selectively treat different regions of the bronchus in different ways. That is, while the particular sub-bronchial region which is isolated by the distal isolation cuff may be treated in one way, the remainder of that bronchus as well as the entire other lung must be ventilated and treated in a common manner through either the endotracheal tube or the outer catheter of the co-axial catheter pair.
  • the present invention should provide for the efficient delivery of pharmaceutical and other substances to the targeted sub-lobar regions of the lung. Moreover, in some embodiments, the present invention should be able to provide at least a second level of isolation within a particular bronchus and/or the ability to instill the pharmaceuticals or other substances at a point significantly distal to a point of isolation within the bronchus.
  • the systems and apparatus of the present invention should be capable of being positioned precisely to a targeted bronchi within the bronchus, preferably providing on-board visualization while components of the system are positioned over a guidewire.
  • the apparatus, systems, methods, and kits of the present invention should be suitable for a wide variety of purposes, including pharmaceutical drug delivery, lung lavage (optionally in combination with drug delivery), diagnosis (optionally in combination with lung lavage), and the like.
  • the present invention should be useful for localized drug delivery where a particular drug or other therapeutic agent can be delivered to a well-defined, isolated sub-bronchial region of the lung (as defined hereinafter) with little or no delivery to other regions of the lung. At least some of these objectives will be met by the inventions described hereinafter.
  • WO 92/10971 describes a bronchoalveolar lavage catheter system having an outer catheter and an inner catheter with an enlarged (optionally inflatable) tip which is advanced until the tip wedges in a bronchiole of the patient. A region of the lungs distal to the enlarged tip may then be lavaged to retrieve sample.
  • U.S. Pat. Nos. 5,660,175; 5,653,231; 4,716,896; and 4,453,545, describe single and co-axial catheter systems for accessing a patient's lungs.
  • U.S. Pat. No. 5,285,778, describes a co-axial endoscopic lung access system.
  • U.S. Pat. Nos. 5,309,903 and 5,207,220 describe systems for administering liquid pharmaceutical formulations to an isolated lung.
  • the present invention provides improved apparatus, systems, methods, and kits for isolating lobar and sub-lobar regions of a patient's lungs.
  • the isolated region will be a portion (not the whole) of the right or left lung, and isolation will be accomplished by occluding a bronchial passage at at least one location in the lobar, segmental, and subsegmental bronchus.
  • a primary occlusion will be formed after both the main bifurcation of the trachea and a further bifurcation into the lobar bronchus.
  • the lobar and/or sub-lobar region can be further isolated at at least one secondary location distal to the primary point of isolation and usually after further branching of the bronchial passages. Isolation at the primary location and optional additional locations within the bronchial passages will usually be effected by expansion of an occlusion member, such as an inflatable cuff, inflatable balloon, or the like.
  • lobar or sub-lobar region Once the lobar or sub-lobar region has been isolated, a variety of therapeutic and diagnostic procedures can be performed within the isolated region. For example, pharmaceutical formulations including small molecule drugs, biological macromolecular drugs, and the like, can be specifically delivered to the isolated region with minimal or no cross-delivery to other regions of the lungs. Similarly, lavage may be performed within the isolated region with minimal impact on adjacent regions of the lungs. Isolation of the lobar or sub-lobar region permits such drug delivery and lavage procedures to be further controlled by control of the volumes, rates, pressures, temperatures, repetitions, retention times, and other method and system parameters. For example, the pressure within the isolated region can be controlled separately from the pressure or pressures maintained outside of the isolated region.
  • the isolated lobar or sub-lobar region will be expanded which may, in some cases, enhance delivery of a drug or permit more efficient lavage of the region.
  • the risk of migration of toxic therapeutic or other agents away from the isolated region can be greatly reduced.
  • an isolation catheter comprises a catheter body having a proximal end, a distal end, and a main lumen therebetween.
  • An expansible occlusion member is disposed at or near the distal end of the catheter body, and optical and illumination fibers are disposed in the catheter body to permit imaging of a region distal to the distal end of the catheter body when the catheter is in use.
  • a hub will be attached to the proximal end of the catheter and include at least one connection port for the main lumen of the catheter.
  • the hub will contain a second connection port for the optical and illumination fibers, and may contain further connection ports for other lumens and capabilities of the catheter, as described hereinafter.
  • the catheter body of the isolation catheter will be adapted and sized to allow advancement of the distal end of the catheter body to a target bronchial passage within the lung which is located distal to a first branching of the right or left main stem bronchus.
  • a distal region of the catheter body will have an outer diameter which is sufficiently small and flexible to be advanced into bronchioles having a diameter below about 12 mm, preferably below about 10 mm, and often below about 8 mm.
  • Exemplary catheter bodies will have a length in the range from 40 cm to 150 cm, preferably from 50 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm, preferably from 3 mm to 6 mm, and a main lumen diameter in the range from 1 mm to 6 mm, preferably from 2 mm to 4 mm.
  • the expansible occlusion member will typically be an inflatable cuff or balloon having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm.
  • the catheter body will include at least one additional lumen for inflation of the inflatable cuff, and the additional lumen will be connected to an additional connector port on the catheter hub. Further optionally, the catheter body may include an additional lumen disposed to direct a washing fluid over a distal tip of the optical fiber which terminates at or near the distal end of the catheter body.
  • systems according to the present invention comprises an isolation catheter as described above combined with an inner catheter to form a lung infusion/aspiration system.
  • the inner catheter has a proximal end, a distal end, and a central lumen extending between the proximal end and distal end.
  • the inner catheter is positionable within the main lumen of the isolation catheter so that the catheters may be used together in a co-axial fashion and further so that an annular lumen is formed within the main lumen of the isolation catheter, i.e., between an inner surface of the main lumen of the isolation catheter and an outer surface of the inner catheter.
  • the connector port on the isolation catheter has an additional connector port for the annular lumen.
  • the system may comprise an adapter connectable to the hub on the isolation catheter, where the adapter has a connector port for the annular lumen.
  • the dimensions and physical characteristics of the inner catheter will be chosen to permit introduction through the main lumen of the isolation catheter and further to permit advancement of the inner catheter beyond the distal end of the isolation catheter into bronchial passages or bronchioles distal to the isolation catheter when in use.
  • An exemplary inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, preferably from 1.5 mm to 3.5 mm, an inner lumen diameter in the range from 0.1 mm to 3.5 mm, preferably from 1 mm to 3 mm, and a length which is at least 10 cm longer than the isolation catheter in the system.
  • the inner catheter will have a length in the range from 50 cm to 200 cm, preferably from 60 cm to 110 cm.
  • the inner catheter may have an expansible occlusion member disposed near its distal end to permit selective isolation of a lobar or sub-lobar region between proximal and distal points along the bronchial passages of the lung.
  • the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm.
  • the inner catheter When including an inflatable cuff, the inner catheter will usually further comprise an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff. Moreover, when provided with an inflatable cuff, the inner catheter will usually comprise an infusion/aspiration lumen having a distal port position proximally of the inflatable cuff so that substances, washing fluids, or the like, may be delivered or aspirated through the lumen between the inflatable cuff on the isolation catheter and the inflatable cuff on the inner catheter. Still further optionally, the inner catheter may comprise a vibratory element, such as an ultrasonic transducer, near its distal end to assist in dissolution of occlusive materials, enhance drug uptake, or the like.
  • a vibratory element such as an ultrasonic transducer
  • the inner catheter may comprise two or more lumens, where at least two of the lumens are joined near a distal end to permit mixing of two or more gas or liquid streams which are being delivered through the catheter. The mixed streams are then released through a common outlet port on the inner catheter.
  • the two streams may be delivered in parallel from the distal tip of the inner catheter for a variety of purposes.
  • the systems of the present invention may comprise further elements, such as guidewires, tracheal tubes with integral visualization (including both endotracheal and tracheostomy tubes), therapeutic or diagnostic reagents, and/or other system components intended to cooperate in performing the methods of the present invention as described in more detail below.
  • the systems of the present invention may be incorporated into kits where one or more system components are packaged together with instructions for use setting forth the methods described in more detail below. Such kits will usually further comprise packages for holding the system component(s) together with the instructions for use.
  • Methods according to the present invention comprise using an isolation catheter and an inner catheter (generally as described above) for isolating a lobar or sub-lobar region of the lung and then performing a procedure within the isolated region.
  • the methods are used for delivering a substance, typically a drug or other pharmaceutically active substance, to the isolated region.
  • the methods are used for ravaging the isolated region, i.e., introducing and removing a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like, to the region.
  • a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like
  • the lavage and substance delivery methods can be combined where a drug or other active agent is included in the washing liquid which is being used for lavage.
  • the methods of the present invention comprise positioning a distal end of the isolation catheter within a bronchial passage beyond a first branching within the right or left lung.
  • the inner catheter is then positioned through the main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchial passage distally beyond the distal end of the isolation catheter.
  • At least one occlusion element near the distal end of the isolation catheter is expanded within the bronchial passage to isolate a target lobar or sub-lobar region. Thereafter, in the case of drug or other substance delivery, the substance may be delivered through the inner catheter to the isolated region of the lung.
  • the washing liquid may be infused through either (or both) of the inner catheter or the isolation catheter and aspirated through the other (or both) of the two catheters. Infusion and aspiration may be performed sequentially or concurrently, or in combinations of both sequential and concurrent infusion and aspiration. Often, it will be preferred to infuse the washing liquid through the inner catheter so that it enters the isolated region generally in a distal portion thereof and diffuses or migrates back toward the isolation catheter where it is collected and removed. In some instances, the washing liquid drug, or other substance may be introduced as a bolus and held or retained within the isolated sub-lobar region for a pre-selected retention time prior to initiating aspiration.
  • the washing liquid may comprise a drug or other biologically active substance to perform a therapeutic action while the region is being ravaged.
  • the substance may comprise any one of a wide variety of pharmaceutical agents, including small molecule drugs, protein drugs, carbohydrate drugs, nucleic acid drugs (genes, optionally in combination with delivery vectors and/or expression control segments), and the like.
  • the delivered substances may be in the form of an aerosol, optionally produced within the inner catheter or prior to introduction to the inner catheter.
  • the substance may comprise a liquid which is instilled through the inner catheter.
  • it will frequently be preferred to position the isolation catheter and inner catheter through a visualizing endotracheal or tracheostomy tube which has been previously placed in the patient's trachea.
  • Suitable visualizing endotracheal tubes are described, for example, in U.S. Pat. No. 5,285,778, the full disclosure of which is incorporated herein by reference.
  • a visualizing endotracheal or tracheostomy tube will include an inflatable cuff or other occlusion element so that the whole lungs may be isolated from the upper regions of the trachea. In this way, the patient may be ventilated through the tracheal tube while other regions of the lung are isolated.
  • direct visualization at the bifurcation between the left and right lungs helps position in place the isolation catheter to the target region to be isolated.
  • the regions of the lung above or proximal to the occlusion element on the isolation catheter may be ventilated and maintained at a different pressure through the tracheal tube.
  • the isolation catheter, and the inner catheter at least three isolated zones within the lung may be maintained with different pressures being simultaneously maintained.
  • different substances can be delivered to each of these regions through the lumens of the inner catheter, isolation catheter, and the tracheal tube, respectively.
  • pressure within the isolated region may be maintained higher than that within the proximal regions of the lung (where pressure is being controlled through the tracheal tube) resulting in expansion of the isolated region which may be beneficial for a variety of reasons.
  • pressure within the isolated region may be maintained below that of the proximal portions of the lung, reducing the risk of release of materials from the isolated region into the proximal portions of the lung.
  • a third distal region of the lung may be pressurized separately from the intermediate and proximal regions.
  • the isolation catheter and/or inner catheter will preferably be performed over a guidewire.
  • the guidewire will first be introduced to a point beyond the location in a bronchial passage where it is desired to position a distal end of the isolation catheter and/or inner catheter.
  • the isolation catheter will comprise optical and illumination fibers which permit direct visual observation of the guidewire as the guidewire and isolation catheter are advanced.
  • the guidewire and isolation catheter can be advanced in tandem so that, as successive bifurcations are approached, the physician can steer a curved end of the guidewire into the desired branch bronchial passage.
  • an occlusion cuff may be expanded and the inner catheter optionally introduced over the guidewire or introduced directly through the main lumen of the isolation catheter without a guidewire. While the inner catheter may in some instances incorporate optical and illumination fibers, it will usually not have such imaging capabilities. Thus, positioning of the inner catheter will frequently be done solely by observation from the isolation catheter and/or under fluoroscopic or other external imaging. Of course, positioning of an isolation catheter can also be performed solely under fluoroscopic imaging (or in combination with both direct visual and fluoroscopic imaging), particularly when the isolation catheter does not include imaging capability.
  • the inner catheter may be moved and repositioned within the bronchial passages of the isolated region to deliver a substance or release a washing fluid for lavage at different points within the region.
  • the inner catheter can be moved (i.e., advanced distally or drawn proximally) while the substance or washing liquid is being released in order to better distribute the material within the isolated region.
  • the inner catheter could also be moved through the isolated region in order to aspirate materials which have been introduced, either alone or in combination with aspiration through the main lumen of the isolation catheter.
  • Kits according to the present invention include at least an isolation catheter, and optionally include an inner catheter, a tracheal tube, and/or a guidewire. Other components including medical and bioactive reagents, e.g., drugs, washing liquids, or the like, may also be provided within the kits.
  • the kits will comprise instructions for use setting forth a method of the present invention as generally set forth above.
  • the kits will usually be packaged together in conventional medical packaging, such as a pouch, tray, tube, box, bag, or the like. Instructions for use may be provided on a separate printed sheet, or may printed in whole or in part on the packaging materials. When printed separately, the instructions are commonly referred to as a package insert.
  • at least the isolation catheter and other components of the kit which would be used in the procedure will be packaged in a sterile manner within the kit.
  • FIG. 1 is a side view of a sub-lobar isolation catheter constructed in accordance with the principles of the present invention.
  • FIG. 1A is a cross-sectional view taken along line 1 A- 1 A in FIG. 1.
  • FIG. 1B is an alternative cross-sectional view similar to that shown in FIG. 1A.
  • FIG. 2 is a side view of a first alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
  • FIG. 2A is a cross-sectional view taken along line 2 A- 2 A of FIG. 2.
  • FIG. 3 is a side view of a second alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
  • FIG. 3A is a cross-sectional view taken along line 3 A- 3 A of FIG. 3.
  • FIG. 4 illustrates a system comprising a sub-lobar isolation catheter and an inner catheter constructed in accordance with the principles of the present invention.
  • FIG. 5 is a side view of the inner catheter of FIG. 4 mounted within the sub-lobar isolation catheter, with portions broken away.
  • FIG. 6 illustrates a first alternative construction of the inner catheter of the present invention.
  • FIG. 6A is a cross-sectional view taken along line 6 A- 6 A of FIG. 6.
  • FIG. 7 is a second alternative construction of the inner catheter of the present invention.
  • FIG. 7A is a cross-sectional view taken along line 7 A- 7 A of FIG. 7.
  • FIG. 8 is a third alternative construction of the inner catheter of the present invention.
  • FIG. 8A is a cross-sectional view taken along line 8 A- 8 A of FIG. 8.
  • FIG. 8B is a detailed view of the distal end of the catheter of FIG. 8 taken along line 8 B- 8 B of FIG. 8.
  • FIG. 9 is a fourth alternative construction of the inner catheter of the present invention.
  • FIG. 9A is a cross-sectional view taken along line 9 A- 9 A of FIG. 9.
  • FIG. 10 illustrates introduction of a sub-lobar isolation catheter to a diseased region within a lung according to the method of the present invention.
  • FIG. 11 is a detailed view of the introduction of FIG. 10 shown with the isolation catheter being passed through a visualizing endotracheal tube.
  • FIGS. 12 A- 12 C illustrate use of the various inner catheters for performing particular procedures in accordance with the principles of the present invention.
  • FIG. 13 illustrates a kit constructed in accordance with the principles of the present invention.
  • Isolation of a lobar or sub-lobar region of the lung is accomplished by occluding a lumen of a bronchial passage (bronchiole) at a location distal to a first branch in the network of bronchial passages within the right or left lung.
  • Substances may be delivered to and/or a washing fluid may be used to lavage the isolated lobar or sub-lobar region of the lung by introducing or exchanging materials through a lumen of an isolation catheter, usually in combination with delivery or exchange through a lumen of an associated inner catheter.
  • An inflatable cuff or other expansible isolation element on the isolation catheter is positioned at an isolation location within the bronchial passage, and the cuff inflated.
  • the inner catheter is then positioned at a desired location distal to the end of the isolation catheter, and the isolated region is thus accessible through at least two access lumens, i.e., one lumen through the inner catheter and a second annular lumen between the exterior of the inner catheter and the interior luminal wall of the isolation catheter.
  • access lumens may be used separately or in combination in a variety of ways to perform the methods of the present invention.
  • an isolation catheter 10 comprises a catheter body 12 having a proximal end 16 and a distal end 14 .
  • An inflatable isolation cuff 18 is disposed near the distal end 14 of the catheter body 12 , and an inflation lumen 20 extends through the catheter body from a proximal port 22 on proximal hub 24 to the balloon 18 .
  • the catheter 10 further comprises an optical fiber or bundle 24 and an illumination fiber or bundle 26 , both of which are brought out to a suitable connector 28 through a connecting cable 30 .
  • the optical fiber 24 and illuminating fiber 26 may be plugged into a variety of conventional imaging consoles which can provide a real time, visual image looking forwardly from the distal end 14 of the catheter body 12 .
  • the catheter body 12 further includes a main lumen 32 which extends the entire length of the catheter body and passes through connector hub 36 to proximal connector 34 .
  • the main lumen 32 can be used for introducing and/or aspirating materials which are introduced to or withdrawn from an isolated lobar or sub-lobar region of the lung.
  • the main lumen 32 will receive an inner catheter (FIGS. 4 and 5 below), and the isolation catheter and inner catheter will be utilized together for delivering, collecting, and removing materials from an isolated sub-lobar region of the lung.
  • the catheter body 12 of the isolation catheter 10 is a single extrusion having four lumens or passages formed therein. Two of the lumens form the inflation lumen 20 and the main lumen 32 , while the other two lumens house the optical fiber bundle 24 and the illumination fiber bundle 26 .
  • the catheter body 12 could also be formed from a plurality of separate tubular members which are held together by an outer cover, as illustrated in FIG. 11B.
  • an inner tube 40 can be disposed in parallel with the optical fiber bundle 24 and the illuminating fiber bundle 26 .
  • a separate tubular member 42 can also be placed co-axially on the exterior of tube 40 , and all of the components held together by a cover 44 which may, for example, be shrink-wrapped over the assembly.
  • An inflation lumen 46 is then provided in the space under the cover 44 which is unoccupied by the optical and tubular components.
  • a variety of other specific construction designs may also be provided.
  • the catheter body 12 may be formed from conventional materials, such as polyamides (nylons), polyethylenes, polyurethanes, polytetrafluoroethylenes (PTFEs), polyimides, and the like.
  • the inflatable cuff can be formed from other conventional materials, such as polyvinylchloride, polyurethanes, high density polyethylenes, low density polyethylenes, nylons, PTFEs, and the like. Exemplary and preferred dimensions for the catheter body 12 of the isolation catheter 10 have been set forth above.
  • FIGS. 2 and 2A A second exemplary isolation catheter 50 constructed in accordance with the principles of the present invention is illustrated in FIGS. 2 and 2A.
  • the construction of isolation catheter 50 is generally the same as that for isolation catheter 10 , and like components will be given like numbers.
  • catheter 50 includes a lens washing lumen 52 which extends from lens washing port 54 in the hub 56 to a position at the distal tip of the catheter body which lies immediately over a lens (not shown) formed at the distal end of the optical fiber or bundle 26 . Because of the humid and contaminating nature of the lungs, it will be a significant benefit to be able to wash the optical viewing lens whenever the lens becomes obscured to do condensation or fouling.
  • FIGS. 3 and 3A A third exemplary construction of the isolation catheter of the present invention is illustrated in FIGS. 3 and 3A.
  • an isolation catheter 60 comprises generally the same components as catheters 10 and 50 , except that catheter body 12 further includes a lumen 62 which receives a guidewire (or alternatively an articulating steering mechanism) and which extends from port 64 on hub 66 to the distal end 14 of the catheter body 12 .
  • a guidewire or alternatively an articulating steering mechanism
  • isolation catheter 60 is specially adapted for introduction over a guidewire (or other steering mechanism) according to the methods of the present invention and as described in more detail below.
  • the isolation catheter 60 can also include a vibratory element 66 near its distal end.
  • the vibratory element could be a mechanically driven surface, but will usually comprise an ultrasonic transducer intended to deliver vibratory energy to disrupt blockages in the bronchus, enhance drug delivery, or the like.
  • Systems 70 according to the present invention comprise an isolation catheter 10 (or any of the other isolation catheters described above or which would come within the principles of the present invention) and an inner catheter 80 .
  • the inner catheter 80 is sized and adapted to fit within the main lumen 32 of the isolation catheter 10 .
  • the inner catheter 80 has a distal end 82 and a proximal end 84 which terminates in a connecting hub 86 .
  • the isolation catheter 10 includes a hub 96 which is similar to the previously described hubs, except that a proximal end has been modified to slidably receive the inner catheter 80 .
  • an O-ring 90 is provided to provide a sliding pneumatic or hydraulic seal about the inner catheter.
  • an access port 92 is provided in the hub 96 to permit communication with the annular lumen 94 disposed between the exterior of inner catheter 80 and the interior of the main lumen 32 of the isolation catheter 10 .
  • materials can be withdrawn or introduced through the isolation catheter 10 as well as through the lumen of the inner catheter 80 . More particularly, it permits two spaced-apart access points, i.e., at the distal ends of the isolation catheter 10 and inner catheter 80 , respectively, to be established within an isolated lobar or sub-lobar region of the lungs. Using two access points, a variety of substance delivery and lavage protocols can be run, as described in more detail below.
  • Inner catheter 100 includes catheter body 102 having an inflatable isolation cuff 104 near its distal end.
  • a plurality of infusion/aspiration ports 106 are also formed near the distal end 103 of the catheter body 102 and are connected by a lumen 108 to an aspiration/infusion port 110 in proximal hub 112 .
  • the inflatable cuff 104 may be inflated by connecting a suitable inflation source to connector 114 which delivers the inflation medium through lumen 116 to the cuff 104 .
  • a central lumen 120 extends the length of the catheter body from its distal end 103 to a connection port 122 in the hub 112 .
  • infusion/aspiration ports 106 proximal to the inflatable cuff 104 , it will be appreciated that substances may be delivered or removed from a region which is proximal to the cuff 104 but distal to the isolation cuff on the isolation catheter with which the inner catheter 100 is used.
  • FIGS. 7 and 7A Yet a further alternative embodiment of an inner catheter 130 is illustrated in FIGS. 7 and 7A.
  • the inner catheter 130 includes an ultrasonic or other vibratory element 132 (shown in broken line) at or near its distal end 134 .
  • the ultrasonic element 132 may be positioned at the distal end of a lumen 136 which extends through the length of the catheter 130 .
  • the lumen 136 may thus hold wires necessary to power the ultrasonic transducer, where the wires are brought out through a connecting cable 140 and terminate in a plug 142 .
  • An aspiration/infusion lumen 150 also extends the length of the catheter 130 and terminates in a luer or other connector 152 at the proximal end of the catheter.
  • a similar ultrasonic or other vibratory element may be disposed on the isolation catheter, either in addition to or in place of the vibration element 132 on the inner catheter.
  • the vibratory element 66 may also be placed distal to the cuff to deliver energy into an isolated region.
  • the catheter 160 comprises a catheter body 162 having a distal end 164 and a proximal end 166 .
  • a pair of lumens 168 and 170 extend the length of the catheter body 162 from ports 172 and 174 , respectively, and proximal hub of 176 to each of the lumens 168 and 170 is suitable for delivering a material, either liquid, aerosol, or solid (in some flowable form), from the ports 172 and 174 to a mixing region 180 near a distal instillation port 182 at a distal tip of the catheter.
  • air or other gas may be delivered through the larger lumen 170 so that it flows the mixing area 180 .
  • the airflow can act as a Venturi in suspending an aerosolizing material which is delivered to the mixing area.
  • droplets or particulates can be delivered or instilled directly within an isolated lobar or sub-lobar region of the lung.
  • the particulate or droplet size i.e., to arrange generally between 0.1 ⁇ m to 5 ⁇ m
  • absorption of these materials into the alveolar regions of the lungs can be enhanced.
  • the particulate or droplet size outside this range, usually above 5 ⁇ m, preferably above 10 ⁇ m, local delivery (i.e., not systemically absorbed) of a drug or other substance can be achieved.
  • the inner catheter 200 comprises a catheter body 202 having a distal end 204 and a proximal end 206 .
  • the catheter body includes a central lumen 210 and a pair of instillation lumens 212 and 214 .
  • the catheter would be suitable for aerosolization of substances, particularly by delivering a liquid or solid powder substance through one of the lumens 212 and air or other aerosolization gas through the other lumen 214 .
  • the central lumen 210 could be used for aspiration, delivery of other drug materials, or the like.
  • an isolation catheter 10 may be introduced through the mouth, the trachea T and into a lobe L of the lung until it reaches a diseased region DR.
  • the isolation catheter 10 could be introduced through an incision in the neck, usually through a tracheostomy tube.
  • cuff 18 may be inflated to isolate regions of the lung distal to the inflated cuff in the bronchial passage. As illustrated in FIG.
  • catheter 10 may optionally be delivered through a visualizing endotracheal tube VETT (or visualizing tracheostomy tube), where a cuff C on the tube is inflated within the trachea T at a region just above the main lung bifurcation into the right and left lungs RL and LL.
  • the isolation catheter 10 may be advanced over a guidewire GW, where visualization of the guidewire immediately ahead of the catheter may be observed on the video screen V attached to the optical and illumination fibers within the catheter 10 .
  • the guidewire may be advanced just ahead of the distal end of the catheter 10 in tandem so that the guidewire can be observed as it is rotated and introduced selectively into the bronchial passages at bifurcations.
  • advancement of the catheter 10 may be observed fluoroscopically or using any other available external imaging systems.
  • the inflatable cuff 18 may be inflated to both anchor the distal end of the catheter and isolate regions of the lung distal thereto.
  • the inner catheter 80 may be advanced through the main lumen 34 so that the distal end 82 of the inner catheter progresses distally into a desired bronchial passage. Advancement of the distal end 82 may optionally be over a guidewire and will usually be performed under visual imaging using the optical illuminating fibers in the isolation catheter 10 .
  • a drug can be delivered through the distal end 82 of the inner catheter to treat a target region TR, shown in broken line in FIG. 12B, additionally or alternatively, the target region TR can be lavaged by introducing a washing fluid through either catheter 10 or 80 and/or collecting the fluid through either of catheter 10 or 80 .
  • inner catheter 100 having inflatable cuff 104 at its distal end may be introduced through the isolation catheter 10 .
  • a modified target region MTR can be defined.
  • the target region MTR in FIG. 12C will be more limited in volume than that formed in FIG. 12B where there is no distal isolation.
  • Use of the second isolation cuff 104 on the inner catheter 100 permits much more specifically focused treatment protocols, both drug delivery and lavage, to be performed. By delivering or aspirating the materials through the ports 106 , it will be appreciated that the treatment is substantially limited to between the two cuffs 18 and 104 .
  • kits 300 will comprise at least a lobar or sub-lobar isolation catheter 10 and an inner catheter 80 together with instructions for use IFU.
  • the kits may further include other system components as described above, such as a visualizing endotracheal tube VET, a guidewire GW, and/or various reagents (not shown).
  • the instructions for use IFU will set forth any of the methods as described above, and all kit components will usually be packaged together in a suitable package 350 , such as a pouch, tray, tube, box, bag, or the like.
  • kits components such as the isolation catheter 10 and inner catheter 80 , which will be used in performing the procedure on the patient, will be sterilized and maintained sterilely within the kit.
  • separate pouches, bags, trays, or other packaging materials may be provided within a larger package, where the smaller packs may be separately opened and will separately maintain the components in a sterile fashion.

Abstract

Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • This application is a division of application Ser. No. 09/425,272, filed on Oct. 21, 1998, now U.S. Pat. No. ______, the full disclosure of which is incorporated herein by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • The present invention relates generally to medical apparatus, systems, methods, and kits. More particularly, the present invention relates to methods and apparatus for isolating sub-bronchial regions of the lung and delivering or retrieving substances from such isolated regions. [0003]
  • Lung access and isolation is of interest in numerous therapeutic and diagnostic medical procedures. In particular, access to the lungs is useful for both local and systemic drug delivery, lung lavage, visual assessment and diagnosis of lung function, and the like. [0004]
  • For drug delivery, access is most simply achieved by introducing an aerosol to the lungs through the mouth or nose, and a variety of inhalers, nebulizers, metered dose inhalers (MDIs), nasal sprayers, and the like, have been developed over the years. While very effective for many drugs, delivery through the mouth or nose can be very inefficient, often with less than 20% of the drug reaching circulation or a targeted local treatment region. Moreover, inhalation through the mouth or nose is not able to target drug delivery to a particular region of the lungs. While this may not be a problem for systemic delivery, it can be a significant drawback in the treatment of localized disease where a highly controlled delivery profile would be preferred. [0005]
  • In an effort to overcome at least some of these shortcomings, a variety of endotracheal drug delivery and lung lavage systems have been developed. Most simply, an endotracheal or tracheostomy tube having an inflatable cuff at its distal end may be placed in a patient's trachea and used to deliver a drug aerosol to the whole of the lungs. While this can improve the efficiency of drug delivery (reducing the amount of drug deposited in the nasal passages or throat), it helps little in targeting treatment within any particular region of the lungs. Thus, it has been further proposed to use a secondary catheter placed through an endotracheal or tracheostomy tube for selectively isolating the left or right bronchus. For example, the secondary catheter can have an inflatable cuff which is positioned immediately beyond the main branching between the left and right bronchi. One of the bronchi can then be accessed through the secondary catheter while the other is accessed through the tracheal tube. Such systems are described, for example, in U.S. Pat. Nos. 5,285,778 and 5,660,175. While such systems offer significant benefits over the use of an endotracheal tube by itself, they still do not permit isolation of sub-bronchial regions of the lung for drug delivery, lavage, or any other purpose. [0006]
  • A system for bronchoalveolar lavage which can isolate a sub-bronchial region of the lung is described in published Application No. WO 92/10971. A co-axial catheter system is placed through an endotracheal tube, with the inner most catheter having an isolation wedge or balloon which can be positioned in a remote bronchiole to effect isolation of a distal region of the lung. The outer catheter has no capability for isolating the lung and is used, for example, for ventilating the lung proximal to the isolation cuff. While potentially an improvement over prior systems, the apparatus of [0007] WO 92/10971 will be very difficult to position, making targeting of particular sub-bronchial regions very difficult. Moreover, the inability to isolate a bronchus upstream from the distal isolation cuff limits the ability to selectively treat different regions of the bronchus in different ways. That is, while the particular sub-bronchial region which is isolated by the distal isolation cuff may be treated in one way, the remainder of that bronchus as well as the entire other lung must be ventilated and treated in a common manner through either the endotracheal tube or the outer catheter of the co-axial catheter pair.
  • For these reasons, it would be desirable to provide improved apparatus, systems, methods, and kits for the treatment and diagnosis of selected regions of a patient's lungs, particularly a lobar or targeted sub-lobar regions of the patient's lungs. The present invention should provide for the efficient delivery of pharmaceutical and other substances to the targeted sub-lobar regions of the lung. Moreover, in some embodiments, the present invention should be able to provide at least a second level of isolation within a particular bronchus and/or the ability to instill the pharmaceuticals or other substances at a point significantly distal to a point of isolation within the bronchus. The systems and apparatus of the present invention should be capable of being positioned precisely to a targeted bronchi within the bronchus, preferably providing on-board visualization while components of the system are positioned over a guidewire. Additionally, the apparatus, systems, methods, and kits of the present invention should be suitable for a wide variety of purposes, including pharmaceutical drug delivery, lung lavage (optionally in combination with drug delivery), diagnosis (optionally in combination with lung lavage), and the like. In particular, the present invention should be useful for localized drug delivery where a particular drug or other therapeutic agent can be delivered to a well-defined, isolated sub-bronchial region of the lung (as defined hereinafter) with little or no delivery to other regions of the lung. At least some of these objectives will be met by the inventions described hereinafter. [0008]
  • 2. Description of the Background Art [0009]
  • WO 92/10971 describes a bronchoalveolar lavage catheter system having an outer catheter and an inner catheter with an enlarged (optionally inflatable) tip which is advanced until the tip wedges in a bronchiole of the patient. A region of the lungs distal to the enlarged tip may then be lavaged to retrieve sample. U.S. Pat. Nos. 5,660,175; 5,653,231; 4,716,896; and 4,453,545, describe single and co-axial catheter systems for accessing a patient's lungs. U.S. Pat. No. 5,285,778, describes a co-axial endoscopic lung access system. U.S. Pat. Nos. 5,309,903 and 5,207,220 describe systems for administering liquid pharmaceutical formulations to an isolated lung. [0010]
  • BRIEF SUMMARY OF THE INVENTION
  • The present invention provides improved apparatus, systems, methods, and kits for isolating lobar and sub-lobar regions of a patient's lungs. The isolated region will be a portion (not the whole) of the right or left lung, and isolation will be accomplished by occluding a bronchial passage at at least one location in the lobar, segmental, and subsegmental bronchus. Thus, a primary occlusion will be formed after both the main bifurcation of the trachea and a further bifurcation into the lobar bronchus. Optionally, the lobar and/or sub-lobar region can be further isolated at at least one secondary location distal to the primary point of isolation and usually after further branching of the bronchial passages. Isolation at the primary location and optional additional locations within the bronchial passages will usually be effected by expansion of an occlusion member, such as an inflatable cuff, inflatable balloon, or the like. [0011]
  • Once the lobar or sub-lobar region has been isolated, a variety of therapeutic and diagnostic procedures can be performed within the isolated region. For example, pharmaceutical formulations including small molecule drugs, biological macromolecular drugs, and the like, can be specifically delivered to the isolated region with minimal or no cross-delivery to other regions of the lungs. Similarly, lavage may be performed within the isolated region with minimal impact on adjacent regions of the lungs. Isolation of the lobar or sub-lobar region permits such drug delivery and lavage procedures to be further controlled by control of the volumes, rates, pressures, temperatures, repetitions, retention times, and other method and system parameters. For example, the pressure within the isolated region can be controlled separately from the pressure or pressures maintained outside of the isolated region. In this way, a variety of delivery parameters can be controlled. By elevating pressure within the isolated region above that in the surrounding regions of the lung, the isolated lobar or sub-lobar region will be expanded which may, in some cases, enhance delivery of a drug or permit more efficient lavage of the region. Alternatively, by elevating pressure within the “other” lung regions above that within the isolated region, the risk of migration of toxic therapeutic or other agents away from the isolated region can be greatly reduced. [0012]
  • According to the present invention, an isolation catheter comprises a catheter body having a proximal end, a distal end, and a main lumen therebetween. An expansible occlusion member is disposed at or near the distal end of the catheter body, and optical and illumination fibers are disposed in the catheter body to permit imaging of a region distal to the distal end of the catheter body when the catheter is in use. Usually, a hub will be attached to the proximal end of the catheter and include at least one connection port for the main lumen of the catheter. Optionally, the hub will contain a second connection port for the optical and illumination fibers, and may contain further connection ports for other lumens and capabilities of the catheter, as described hereinafter. [0013]
  • The catheter body of the isolation catheter will be adapted and sized to allow advancement of the distal end of the catheter body to a target bronchial passage within the lung which is located distal to a first branching of the right or left main stem bronchus. Usually, at least a distal region of the catheter body will have an outer diameter which is sufficiently small and flexible to be advanced into bronchioles having a diameter below about 12 mm, preferably below about 10 mm, and often below about 8 mm. Exemplary catheter bodies will have a length in the range from 40 cm to 150 cm, preferably from 50 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm, preferably from 3 mm to 6 mm, and a main lumen diameter in the range from 1 mm to 6 mm, preferably from 2 mm to 4 mm. The expansible occlusion member will typically be an inflatable cuff or balloon having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm. Usually, the catheter body will include at least one additional lumen for inflation of the inflatable cuff, and the additional lumen will be connected to an additional connector port on the catheter hub. Further optionally, the catheter body may include an additional lumen disposed to direct a washing fluid over a distal tip of the optical fiber which terminates at or near the distal end of the catheter body. [0014]
  • In a preferred aspect, systems according to the present invention comprises an isolation catheter as described above combined with an inner catheter to form a lung infusion/aspiration system. The inner catheter has a proximal end, a distal end, and a central lumen extending between the proximal end and distal end. The inner catheter is positionable within the main lumen of the isolation catheter so that the catheters may be used together in a co-axial fashion and further so that an annular lumen is formed within the main lumen of the isolation catheter, i.e., between an inner surface of the main lumen of the isolation catheter and an outer surface of the inner catheter. Optionally, the connector port on the isolation catheter has an additional connector port for the annular lumen. Alternatively, the system may comprise an adapter connectable to the hub on the isolation catheter, where the adapter has a connector port for the annular lumen. The dimensions and physical characteristics of the inner catheter will be chosen to permit introduction through the main lumen of the isolation catheter and further to permit advancement of the inner catheter beyond the distal end of the isolation catheter into bronchial passages or bronchioles distal to the isolation catheter when in use. [0015]
  • An exemplary inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, preferably from 1.5 mm to 3.5 mm, an inner lumen diameter in the range from 0.1 mm to 3.5 mm, preferably from 1 mm to 3 mm, and a length which is at least 10 cm longer than the isolation catheter in the system. Typically, the inner catheter will have a length in the range from 50 cm to 200 cm, preferably from 60 cm to 110 cm. Optionally, the inner catheter may have an expansible occlusion member disposed near its distal end to permit selective isolation of a lobar or sub-lobar region between proximal and distal points along the bronchial passages of the lung. Typically, the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm. [0016]
  • When including an inflatable cuff, the inner catheter will usually further comprise an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff. Moreover, when provided with an inflatable cuff, the inner catheter will usually comprise an infusion/aspiration lumen having a distal port position proximally of the inflatable cuff so that substances, washing fluids, or the like, may be delivered or aspirated through the lumen between the inflatable cuff on the isolation catheter and the inflatable cuff on the inner catheter. Still further optionally, the inner catheter may comprise a vibratory element, such as an ultrasonic transducer, near its distal end to assist in dissolution of occlusive materials, enhance drug uptake, or the like. Still further optionally, the inner catheter may comprise two or more lumens, where at least two of the lumens are joined near a distal end to permit mixing of two or more gas or liquid streams which are being delivered through the catheter. The mixed streams are then released through a common outlet port on the inner catheter. Alternatively, the two streams may be delivered in parallel from the distal tip of the inner catheter for a variety of purposes. [0017]
  • The systems of the present invention may comprise further elements, such as guidewires, tracheal tubes with integral visualization (including both endotracheal and tracheostomy tubes), therapeutic or diagnostic reagents, and/or other system components intended to cooperate in performing the methods of the present invention as described in more detail below. Additionally, the systems of the present invention may be incorporated into kits where one or more system components are packaged together with instructions for use setting forth the methods described in more detail below. Such kits will usually further comprise packages for holding the system component(s) together with the instructions for use. [0018]
  • Methods according to the present invention comprise using an isolation catheter and an inner catheter (generally as described above) for isolating a lobar or sub-lobar region of the lung and then performing a procedure within the isolated region. In a first instance, the methods are used for delivering a substance, typically a drug or other pharmaceutically active substance, to the isolated region. In a second instance, the methods are used for ravaging the isolated region, i.e., introducing and removing a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like, to the region. Optionally, the lavage and substance delivery methods can be combined where a drug or other active agent is included in the washing liquid which is being used for lavage. The methods of the present invention comprise positioning a distal end of the isolation catheter within a bronchial passage beyond a first branching within the right or left lung. The inner catheter is then positioned through the main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchial passage distally beyond the distal end of the isolation catheter. At least one occlusion element near the distal end of the isolation catheter is expanded within the bronchial passage to isolate a target lobar or sub-lobar region. Thereafter, in the case of drug or other substance delivery, the substance may be delivered through the inner catheter to the isolated region of the lung. In the case of lavage, the washing liquid may be infused through either (or both) of the inner catheter or the isolation catheter and aspirated through the other (or both) of the two catheters. Infusion and aspiration may be performed sequentially or concurrently, or in combinations of both sequential and concurrent infusion and aspiration. Often, it will be preferred to infuse the washing liquid through the inner catheter so that it enters the isolated region generally in a distal portion thereof and diffuses or migrates back toward the isolation catheter where it is collected and removed. In some instances, the washing liquid drug, or other substance may be introduced as a bolus and held or retained within the isolated sub-lobar region for a pre-selected retention time prior to initiating aspiration. In other instances, it may be desirable to continuously both infuse and aspirate the washing liquid drug, or other substance to get a “circulation” of the substance through the isolated lobar or sub-lobar region. Optionally, the washing liquid may comprise a drug or other biologically active substance to perform a therapeutic action while the region is being ravaged. [0019]
  • In the case of substance delivery, the substance may comprise any one of a wide variety of pharmaceutical agents, including small molecule drugs, protein drugs, carbohydrate drugs, nucleic acid drugs (genes, optionally in combination with delivery vectors and/or expression control segments), and the like. The delivered substances may be in the form of an aerosol, optionally produced within the inner catheter or prior to introduction to the inner catheter. Still further optionally, the substance may comprise a liquid which is instilled through the inner catheter. For both substance delivery and lavage, it will frequently be preferred to position the isolation catheter and inner catheter through a visualizing endotracheal or tracheostomy tube which has been previously placed in the patient's trachea. Suitable visualizing endotracheal tubes are described, for example, in U.S. Pat. No. 5,285,778, the full disclosure of which is incorporated herein by reference. Usually, a visualizing endotracheal or tracheostomy tube will include an inflatable cuff or other occlusion element so that the whole lungs may be isolated from the upper regions of the trachea. In this way, the patient may be ventilated through the tracheal tube while other regions of the lung are isolated. Moreover, direct visualization at the bifurcation between the left and right lungs helps position in place the isolation catheter to the target region to be isolated. Additionally, the regions of the lung above or proximal to the occlusion element on the isolation catheter may be ventilated and maintained at a different pressure through the tracheal tube. Thus, by employing isolation cuffs on the tracheal tube, the isolation catheter, and the inner catheter, at least three isolated zones within the lung may be maintained with different pressures being simultaneously maintained. Moreover, different substances can be delivered to each of these regions through the lumens of the inner catheter, isolation catheter, and the tracheal tube, respectively. Often, pressure within the isolated region may be maintained higher than that within the proximal regions of the lung (where pressure is being controlled through the tracheal tube) resulting in expansion of the isolated region which may be beneficial for a variety of reasons. Alternatively, pressure within the isolated region may be maintained below that of the proximal portions of the lung, reducing the risk of release of materials from the isolated region into the proximal portions of the lung. Moreover, when the inner catheter has an isolation cuff, a third distal region of the lung may be pressurized separately from the intermediate and proximal regions. [0020]
  • Introduction of the isolation catheter and/or inner catheter will preferably be performed over a guidewire. The guidewire will first be introduced to a point beyond the location in a bronchial passage where it is desired to position a distal end of the isolation catheter and/or inner catheter. Preferably the isolation catheter will comprise optical and illumination fibers which permit direct visual observation of the guidewire as the guidewire and isolation catheter are advanced. In particular, the guidewire and isolation catheter can be advanced in tandem so that, as successive bifurcations are approached, the physician can steer a curved end of the guidewire into the desired branch bronchial passage. After positioning the isolation catheter at its desired final location, an occlusion cuff may be expanded and the inner catheter optionally introduced over the guidewire or introduced directly through the main lumen of the isolation catheter without a guidewire. While the inner catheter may in some instances incorporate optical and illumination fibers, it will usually not have such imaging capabilities. Thus, positioning of the inner catheter will frequently be done solely by observation from the isolation catheter and/or under fluoroscopic or other external imaging. Of course, positioning of an isolation catheter can also be performed solely under fluoroscopic imaging (or in combination with both direct visual and fluoroscopic imaging), particularly when the isolation catheter does not include imaging capability. [0021]
  • In a further specific aspect of the methods of the present invention, the inner catheter may be moved and repositioned within the bronchial passages of the isolated region to deliver a substance or release a washing fluid for lavage at different points within the region. Optionally, the inner catheter can be moved (i.e., advanced distally or drawn proximally) while the substance or washing liquid is being released in order to better distribute the material within the isolated region. Further optionally, the inner catheter could also be moved through the isolated region in order to aspirate materials which have been introduced, either alone or in combination with aspiration through the main lumen of the isolation catheter. [0022]
  • Kits according to the present invention include at least an isolation catheter, and optionally include an inner catheter, a tracheal tube, and/or a guidewire. Other components including medical and bioactive reagents, e.g., drugs, washing liquids, or the like, may also be provided within the kits. In addition to the isolation catheter and optional other system components, the kits will comprise instructions for use setting forth a method of the present invention as generally set forth above. The kits will usually be packaged together in conventional medical packaging, such as a pouch, tray, tube, box, bag, or the like. Instructions for use may be provided on a separate printed sheet, or may printed in whole or in part on the packaging materials. When printed separately, the instructions are commonly referred to as a package insert. Usually, at least the isolation catheter and other components of the kit which would be used in the procedure will be packaged in a sterile manner within the kit.[0023]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a side view of a sub-lobar isolation catheter constructed in accordance with the principles of the present invention. [0024]
  • FIG. 1A is a cross-sectional view taken along [0025] line 1A-1A in FIG. 1.
  • FIG. 1B is an alternative cross-sectional view similar to that shown in FIG. 1A. [0026]
  • FIG. 2 is a side view of a first alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention. [0027]
  • FIG. 2A is a cross-sectional view taken along [0028] line 2A-2A of FIG. 2.
  • FIG. 3 is a side view of a second alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention. [0029]
  • FIG. 3A is a cross-sectional view taken along [0030] line 3A-3A of FIG. 3.
  • FIG. 4 illustrates a system comprising a sub-lobar isolation catheter and an inner catheter constructed in accordance with the principles of the present invention. [0031]
  • FIG. 5 is a side view of the inner catheter of FIG. 4 mounted within the sub-lobar isolation catheter, with portions broken away. [0032]
  • FIG. 6 illustrates a first alternative construction of the inner catheter of the present invention. [0033]
  • FIG. 6A is a cross-sectional view taken along [0034] line 6A-6A of FIG. 6.
  • FIG. 7 is a second alternative construction of the inner catheter of the present invention. [0035]
  • FIG. 7A is a cross-sectional view taken along [0036] line 7A-7A of FIG. 7.
  • FIG. 8 is a third alternative construction of the inner catheter of the present invention. [0037]
  • FIG. 8A is a cross-sectional view taken along [0038] line 8A-8A of FIG. 8.
  • FIG. 8B is a detailed view of the distal end of the catheter of FIG. 8 taken along [0039] line 8B-8B of FIG. 8.
  • FIG. 9 is a fourth alternative construction of the inner catheter of the present invention. [0040]
  • FIG. 9A is a cross-sectional view taken along [0041] line 9A-9A of FIG. 9.
  • FIG. 10 illustrates introduction of a sub-lobar isolation catheter to a diseased region within a lung according to the method of the present invention. [0042]
  • FIG. 11 is a detailed view of the introduction of FIG. 10 shown with the isolation catheter being passed through a visualizing endotracheal tube. [0043]
  • FIGS. [0044] 12A-12C illustrate use of the various inner catheters for performing particular procedures in accordance with the principles of the present invention.
  • FIG. 13 illustrates a kit constructed in accordance with the principles of the present invention.[0045]
  • DETAILED DESCRIPTION OF THE INVENTION
  • Isolation of a lobar or sub-lobar region of the lung is accomplished by occluding a lumen of a bronchial passage (bronchiole) at a location distal to a first branch in the network of bronchial passages within the right or left lung. Substances may be delivered to and/or a washing fluid may be used to lavage the isolated lobar or sub-lobar region of the lung by introducing or exchanging materials through a lumen of an isolation catheter, usually in combination with delivery or exchange through a lumen of an associated inner catheter. An inflatable cuff or other expansible isolation element on the isolation catheter is positioned at an isolation location within the bronchial passage, and the cuff inflated. The inner catheter is then positioned at a desired location distal to the end of the isolation catheter, and the isolated region is thus accessible through at least two access lumens, i.e., one lumen through the inner catheter and a second annular lumen between the exterior of the inner catheter and the interior luminal wall of the isolation catheter. These access lumens may be used separately or in combination in a variety of ways to perform the methods of the present invention. The apparatus and methods of the present invention will now be described in greater detail. [0046]
  • Referring to FIGS. 1 and 1A, an [0047] isolation catheter 10 comprises a catheter body 12 having a proximal end 16 and a distal end 14. An inflatable isolation cuff 18 is disposed near the distal end 14 of the catheter body 12, and an inflation lumen 20 extends through the catheter body from a proximal port 22 on proximal hub 24 to the balloon 18. The catheter 10 further comprises an optical fiber or bundle 24 and an illumination fiber or bundle 26, both of which are brought out to a suitable connector 28 through a connecting cable 30. The optical fiber 24 and illuminating fiber 26 may be plugged into a variety of conventional imaging consoles which can provide a real time, visual image looking forwardly from the distal end 14 of the catheter body 12. Suitable commercial imaging consoles are available from suppliers, such as Pulmonx, Palo Alto, Calif., assignee of the present application as well as Olympus, Pentax and Stryker. The catheter body 12 further includes a main lumen 32 which extends the entire length of the catheter body and passes through connector hub 36 to proximal connector 34. As will be discussed in more detail below, the main lumen 32 can be used for introducing and/or aspirating materials which are introduced to or withdrawn from an isolated lobar or sub-lobar region of the lung. Most usually, the main lumen 32 will receive an inner catheter (FIGS. 4 and 5 below), and the isolation catheter and inner catheter will be utilized together for delivering, collecting, and removing materials from an isolated sub-lobar region of the lung.
  • As shown in FIGS. 1 and 1A, the [0048] catheter body 12 of the isolation catheter 10 is a single extrusion having four lumens or passages formed therein. Two of the lumens form the inflation lumen 20 and the main lumen 32, while the other two lumens house the optical fiber bundle 24 and the illumination fiber bundle 26. The catheter body 12 could also be formed from a plurality of separate tubular members which are held together by an outer cover, as illustrated in FIG. 11B. For example, an inner tube 40 can be disposed in parallel with the optical fiber bundle 24 and the illuminating fiber bundle 26. A separate tubular member 42 can also be placed co-axially on the exterior of tube 40, and all of the components held together by a cover 44 which may, for example, be shrink-wrapped over the assembly. An inflation lumen 46 is then provided in the space under the cover 44 which is unoccupied by the optical and tubular components. A variety of other specific construction designs may also be provided.
  • The [0049] catheter body 12 may be formed from conventional materials, such as polyamides (nylons), polyethylenes, polyurethanes, polytetrafluoroethylenes (PTFEs), polyimides, and the like. The inflatable cuff can be formed from other conventional materials, such as polyvinylchloride, polyurethanes, high density polyethylenes, low density polyethylenes, nylons, PTFEs, and the like. Exemplary and preferred dimensions for the catheter body 12 of the isolation catheter 10 have been set forth above.
  • A second [0050] exemplary isolation catheter 50 constructed in accordance with the principles of the present invention is illustrated in FIGS. 2 and 2A. The construction of isolation catheter 50 is generally the same as that for isolation catheter 10, and like components will be given like numbers. The principal difference between the catheters 50 and 10 is that catheter 50 includes a lens washing lumen 52 which extends from lens washing port 54 in the hub 56 to a position at the distal tip of the catheter body which lies immediately over a lens (not shown) formed at the distal end of the optical fiber or bundle 26. Because of the humid and contaminating nature of the lungs, it will be a significant benefit to be able to wash the optical viewing lens whenever the lens becomes obscured to do condensation or fouling.
  • A third exemplary construction of the isolation catheter of the present invention is illustrated in FIGS. 3 and 3A. There, an [0051] isolation catheter 60 comprises generally the same components as catheters 10 and 50, except that catheter body 12 further includes a lumen 62 which receives a guidewire (or alternatively an articulating steering mechanism) and which extends from port 64 on hub 66 to the distal end 14 of the catheter body 12. Thus, isolation catheter 60 is specially adapted for introduction over a guidewire (or other steering mechanism) according to the methods of the present invention and as described in more detail below. It will be appreciated, of course, that the earlier embodiments could also be introduced over a guidewire where the guidewire is passed through the main lumen 32, but in such cases the main lumen would have to be emptied i.e., the inner catheter (if used) would have to be removed from the isolation catheter. Optionally, the isolation catheter 60 can also include a vibratory element 66 near its distal end. The vibratory element could be a mechanically driven surface, but will usually comprise an ultrasonic transducer intended to deliver vibratory energy to disrupt blockages in the bronchus, enhance drug delivery, or the like.
  • [0052] Systems 70 according to the present invention comprise an isolation catheter 10 (or any of the other isolation catheters described above or which would come within the principles of the present invention) and an inner catheter 80. As illustrated in FIGS. 4 and 5, the inner catheter 80 is sized and adapted to fit within the main lumen 32 of the isolation catheter 10. The inner catheter 80 has a distal end 82 and a proximal end 84 which terminates in a connecting hub 86. The isolation catheter 10 includes a hub 96 which is similar to the previously described hubs, except that a proximal end has been modified to slidably receive the inner catheter 80. As shown, an O-ring 90 is provided to provide a sliding pneumatic or hydraulic seal about the inner catheter. Additionally, an access port 92 is provided in the hub 96 to permit communication with the annular lumen 94 disposed between the exterior of inner catheter 80 and the interior of the main lumen 32 of the isolation catheter 10. In this way, materials can be withdrawn or introduced through the isolation catheter 10 as well as through the lumen of the inner catheter 80. More particularly, it permits two spaced-apart access points, i.e., at the distal ends of the isolation catheter 10 and inner catheter 80, respectively, to be established within an isolated lobar or sub-lobar region of the lungs. Using two access points, a variety of substance delivery and lavage protocols can be run, as described in more detail below.
  • A first alternative embodiment of an [0053] inner catheter 100 is illustrated in FIGS. 6 and 6A. Inner catheter 100 includes catheter body 102 having an inflatable isolation cuff 104 near its distal end. A plurality of infusion/aspiration ports 106 are also formed near the distal end 103 of the catheter body 102 and are connected by a lumen 108 to an aspiration/infusion port 110 in proximal hub 112. The inflatable cuff 104 may be inflated by connecting a suitable inflation source to connector 114 which delivers the inflation medium through lumen 116 to the cuff 104. A central lumen 120 extends the length of the catheter body from its distal end 103 to a connection port 122 in the hub 112. By providing the infusion/aspiration ports 106 proximal to the inflatable cuff 104, it will be appreciated that substances may be delivered or removed from a region which is proximal to the cuff 104 but distal to the isolation cuff on the isolation catheter with which the inner catheter 100 is used.
  • Yet a further alternative embodiment of an [0054] inner catheter 130 is illustrated in FIGS. 7 and 7A. The inner catheter 130 includes an ultrasonic or other vibratory element 132 (shown in broken line) at or near its distal end 134. The ultrasonic element 132 may be positioned at the distal end of a lumen 136 which extends through the length of the catheter 130. The lumen 136 may thus hold wires necessary to power the ultrasonic transducer, where the wires are brought out through a connecting cable 140 and terminate in a plug 142. An aspiration/infusion lumen 150 also extends the length of the catheter 130 and terminates in a luer or other connector 152 at the proximal end of the catheter. Optionally, a similar ultrasonic or other vibratory element may be disposed on the isolation catheter, either in addition to or in place of the vibration element 132 on the inner catheter. Although shown proximal to cuff 18, the vibratory element 66 may also be placed distal to the cuff to deliver energy into an isolated region.
  • Referring now to FIGS. 8, 8A, and [0055] 8B, still a further embodiment of an inner catheter 160 will be described. The catheter 160 comprises a catheter body 162 having a distal end 164 and a proximal end 166. A pair of lumens 168 and 170 extend the length of the catheter body 162 from ports 172 and 174, respectively, and proximal hub of 176 to each of the lumens 168 and 170 is suitable for delivering a material, either liquid, aerosol, or solid (in some flowable form), from the ports 172 and 174 to a mixing region 180 near a distal instillation port 182 at a distal tip of the catheter. For example, air or other gas may be delivered through the larger lumen 170 so that it flows the mixing area 180. By delivering a liquid or powder through the smaller lumen 168, the airflow can act as a Venturi in suspending an aerosolizing material which is delivered to the mixing area. In this way, droplets or particulates can be delivered or instilled directly within an isolated lobar or sub-lobar region of the lung. By properly controlling the particulate or droplet size, i.e., to arrange generally between 0.1 μm to 5 μm, absorption of these materials into the alveolar regions of the lungs can be enhanced. By controlling the particulate or droplet size outside this range, usually above 5 μm, preferably above 10 μm, local delivery (i.e., not systemically absorbed) of a drug or other substance can be achieved.
  • Referring now to FIGS. 9 and 9A, still yet a further embodiment of an [0056] inner catheter 200 constructed in accordance with the principles of the present invention will be described. The inner catheter 200 comprises a catheter body 202 having a distal end 204 and a proximal end 206. The catheter body includes a central lumen 210 and a pair of instillation lumens 212 and 214. The catheter would be suitable for aerosolization of substances, particularly by delivering a liquid or solid powder substance through one of the lumens 212 and air or other aerosolization gas through the other lumen 214. The central lumen 210 could be used for aspiration, delivery of other drug materials, or the like.
  • Referring now to FIGS. 10, 11, and [0057] 12A-12C, methods according to the present invention will be described. Most generally, an isolation catheter 10 may be introduced through the mouth, the trachea T and into a lobe L of the lung until it reaches a diseased region DR. Alternatively, the isolation catheter 10 could be introduced through an incision in the neck, usually through a tracheostomy tube. At that point, cuff 18 may be inflated to isolate regions of the lung distal to the inflated cuff in the bronchial passage. As illustrated in FIG. 11, catheter 10 may optionally be delivered through a visualizing endotracheal tube VETT (or visualizing tracheostomy tube), where a cuff C on the tube is inflated within the trachea T at a region just above the main lung bifurcation into the right and left lungs RL and LL. Further optionally, the isolation catheter 10 may be advanced over a guidewire GW, where visualization of the guidewire immediately ahead of the catheter may be observed on the video screen V attached to the optical and illumination fibers within the catheter 10. In particular, the guidewire may be advanced just ahead of the distal end of the catheter 10 in tandem so that the guidewire can be observed as it is rotated and introduced selectively into the bronchial passages at bifurcations. Alternatively, or additionally, advancement of the catheter 10 may be observed fluoroscopically or using any other available external imaging systems.
  • Once the [0058] catheter 10 is in place beyond a second bifurcation SB in the bronchial passages, as illustrated in FIG. 12A, the inflatable cuff 18 may be inflated to both anchor the distal end of the catheter and isolate regions of the lung distal thereto. After the cuff 18 is inflated, the inner catheter 80 may be advanced through the main lumen 34 so that the distal end 82 of the inner catheter progresses distally into a desired bronchial passage. Advancement of the distal end 82 may optionally be over a guidewire and will usually be performed under visual imaging using the optical illuminating fibers in the isolation catheter 10. Once the inner catheter has been properly positioned, as shown in FIG. 12B, a desired procedure can be performed. For example, a drug can be delivered through the distal end 82 of the inner catheter to treat a target region TR, shown in broken line in FIG. 12B, additionally or alternatively, the target region TR can be lavaged by introducing a washing fluid through either catheter 10 or 80 and/or collecting the fluid through either of catheter 10 or 80.
  • Alternatively, as shown in FIG. 12C, [0059] inner catheter 100 having inflatable cuff 104 at its distal end may be introduced through the isolation catheter 10. By then inflating cuff 104 distally relative to cuff 18 on isolation catheter 10, a modified target region MTR can be defined. In particular, the target region MTR in FIG. 12C will be more limited in volume than that formed in FIG. 12B where there is no distal isolation. Use of the second isolation cuff 104 on the inner catheter 100 permits much more specifically focused treatment protocols, both drug delivery and lavage, to be performed. By delivering or aspirating the materials through the ports 106, it will be appreciated that the treatment is substantially limited to between the two cuffs 18 and 104.
  • Referring now to FIG. 13, a [0060] kit 300 according to the present invention will comprise at least a lobar or sub-lobar isolation catheter 10 and an inner catheter 80 together with instructions for use IFU. Optionally, the kits may further include other system components as described above, such as a visualizing endotracheal tube VET, a guidewire GW, and/or various reagents (not shown). The instructions for use IFU will set forth any of the methods as described above, and all kit components will usually be packaged together in a suitable package 350, such as a pouch, tray, tube, box, bag, or the like. Usually, those kits components, such as the isolation catheter 10 and inner catheter 80, which will be used in performing the procedure on the patient, will be sterilized and maintained sterilely within the kit. Optionally, separate pouches, bags, trays, or other packaging materials may be provided within a larger package, where the smaller packs may be separately opened and will separately maintain the components in a sterile fashion.
  • While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims. [0061]

Claims (17)

What is claimed is:
1. An isolation catheter comprising:
a catheter body having a proximal end, a distal end, and a main lumen therethrough;
an expansible occlusion member disposed on the catheter body near the distal end thereof;
optical and illumination fibers disposed in the catheter body to image a region distal to the distal end of the catheter body; and
a hub attached to the proximal end of the catheter body, said hub having a connector port for at least the main lumen.
2. An isolation catheter as in claim 1, wherein the catheter body has a length in the range from 20 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm and the main lumen has a diameter from 1 mm to 6 mm.
3. An isolation catheter as in either claim 1 or 2, wherein the expansible occlusion member is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm and a length in the range from 5 mm to 30 mm.
4. An isolation catheter as in claim 3, wherein the catheter body further comprises an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff and wherein the hub has an additional connector port for the inflation lumen.
5. An isolation catheter as in either claim 1 or 2, wherein the catheter body further comprises a lumen disposed to direct a washing fluid over a distal tip of the optical fiber.
6. An isolation lung infusion/aspiration system, said system comprising:
an isolation catheter according to either of claims 1 and 2; and
an inner catheter having a proximal end, a distal end, and a central lumen therethrough, said inner catheter being positionable within the main lumen of the sub-lobar isolation catheter to form an annular lumen within the main lumen.
7. A system as in claim 6, wherein the hub has an additional connector port for the annular lumen.
8. A system as in claim 6, further comprising an adaptor connectable to the hub, wherein the adaptor has a connector port for the annular lumen.
9. A system as in claim 6, wherein the inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, an inner diameter in the range from 0.1 mm to 3.5 mm, and a length at least 10 cm longer than the isolation catheter.
10. A system as in claim 9, wherein the inner catheter has a length in the range from 50 cm to 200 cm.
11. A system as in claim 6, wherein the inner catheter has an expansible occlusion member disposed near its distal end.
12. A system as in claim 11, wherein the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, and a length in the range from 5 mm to 30 mm.
13. A system as in claim 11, wherein the inner catheter further comprises an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff on the inner catheter.
14. A system as in claim 6, wherein the inner catheter further comprises an infusion/aspiration lumen having at least one distal port positioned proximally of the inflatable cuff on the inner catheter.
15. A system as in claim 6, wherein the inner catheter further comprises a vibratory element near the distal end thereof.
16. A system as in claim 6, wherein the inner catheter comprises at least two lumens which are joined near a distal end of the inner catheter and which have a common outlet port.
17. An isolation catheter as in claim 1 or 2, further comprising a vibratory element near the distal end thereof.
US10/074,861 1999-10-21 2002-02-11 Apparatus and method for isolated lung access Abandoned US20020077593A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US09/425,272 US6398775B1 (en) 1999-10-21 1999-10-21 Apparatus and method for isolated lung access
PCT/US2000/029417 WO2003105941A1 (en) 1999-10-21 2000-10-24 Apparatus and method for isolated lung access
US10/074,861 US20020077593A1 (en) 1999-10-21 2002-02-11 Apparatus and method for isolated lung access

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/425,272 US6398775B1 (en) 1999-10-21 1999-10-21 Apparatus and method for isolated lung access
PCT/US2000/029417 WO2003105941A1 (en) 1999-10-21 2000-10-24 Apparatus and method for isolated lung access
US10/074,861 US20020077593A1 (en) 1999-10-21 2002-02-11 Apparatus and method for isolated lung access

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/425,272 Division US6398775B1 (en) 1999-10-21 1999-10-21 Apparatus and method for isolated lung access

Publications (1)

Publication Number Publication Date
US20020077593A1 true US20020077593A1 (en) 2002-06-20

Family

ID=32234041

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/425,272 Expired - Lifetime US6398775B1 (en) 1999-10-21 1999-10-21 Apparatus and method for isolated lung access
US10/074,861 Abandoned US20020077593A1 (en) 1999-10-21 2002-02-11 Apparatus and method for isolated lung access

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/425,272 Expired - Lifetime US6398775B1 (en) 1999-10-21 1999-10-21 Apparatus and method for isolated lung access

Country Status (2)

Country Link
US (2) US6398775B1 (en)
WO (1) WO2003105941A1 (en)

Cited By (142)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020095209A1 (en) * 1997-09-16 2002-07-18 Gholam-Reza Zadno-Azizi Body fluid flow control device
US20020112729A1 (en) * 2001-02-21 2002-08-22 Spiration, Inc. Intra-bronchial obstructing device that controls biological interaction with the patient
US20030070682A1 (en) * 2001-10-11 2003-04-17 Wilson Peter M. Bronchial flow control devices and methods of use
US20030158515A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20030183235A1 (en) * 2001-10-25 2003-10-02 Spiration, Inc. Bronchial obstruction device deployment system and method
US20030195385A1 (en) * 2002-04-16 2003-10-16 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20030212412A1 (en) * 2002-05-09 2003-11-13 Spiration, Inc. Intra-bronchial obstructing device that permits mucus transport
US20030216769A1 (en) * 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US20030228344A1 (en) * 2002-03-08 2003-12-11 Fields Antony J. Methods and devices for inducing collapse in lung regions fed by collateral pathways
US6679264B1 (en) 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
EP1386635A1 (en) * 2002-07-31 2004-02-04 Cordis Corporation Long term oxygen therapy system
US20040039250A1 (en) * 2002-05-28 2004-02-26 David Tholfsen Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment
US20040055606A1 (en) * 2001-03-02 2004-03-25 Emphasys Medical, Inc. Bronchial flow control devices with membrane seal
US20040060563A1 (en) * 2001-03-02 2004-04-01 Alan Rapacki Bronchial flow control devices and methods of use
US6722360B2 (en) 2000-06-16 2004-04-20 Rajiv Doshi Methods and devices for improving breathing in patients with pulmonary disease
US20040074491A1 (en) * 2001-03-02 2004-04-22 Michael Hendricksen Delivery methods and devices for implantable bronchial isolation devices
US20040078054A1 (en) * 1998-06-05 2004-04-22 Broncus Technologies, Inc. Method for lung volume reduction
US20040148035A1 (en) * 2002-11-27 2004-07-29 Michael Barrett Delivery methods and devices for implantable bronchial isolation devices
US20040200484A1 (en) * 2003-04-08 2004-10-14 Springmeyer Steven C. Bronchoscopic lung volume reduction method
US20040206349A1 (en) * 2001-09-11 2004-10-21 Alferness Clifton A. Removable lung reduction devices, systems, and methods
WO2004064885A3 (en) * 2003-01-20 2004-10-21 Pulmonx Methods and arrangement for reducing the volume of the lung
US20040210248A1 (en) * 2003-03-12 2004-10-21 Spiration, Inc. Apparatus, method and assembly for delivery of intra-bronchial devices
US20040243393A1 (en) * 2003-05-29 2004-12-02 Microsoft Corporation Semantic object synchronous understanding implemented with speech application language tags
US20050051163A1 (en) * 2000-03-04 2005-03-10 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US20050137714A1 (en) * 2003-08-08 2005-06-23 Gonzalez Hugo X. Bronchoscopic repair of air leaks in a lung
US20050178389A1 (en) * 2004-01-27 2005-08-18 Shaw David P. Disease indications for selective endobronchial lung region isolation
US20050196344A1 (en) * 2004-02-27 2005-09-08 Mccutcheon John Methods and devices for blocking flow through collateral pathways in the lung
US20050203400A1 (en) * 2003-05-10 2005-09-15 Zappala Stephen M. System and method for precisely identifying a configuration of an anatomical space in real time
US20050222500A1 (en) * 2004-03-01 2005-10-06 Fujinon Corporation Endoscope system and operation method for endoscope
US20060004305A1 (en) * 2002-11-27 2006-01-05 George Robert M Delivery methods and devices for implantable bronchial isolation devices
US20060009748A1 (en) * 2004-06-16 2006-01-12 Mathis Mark L Method of compressing a portion of a lung
US20060020347A1 (en) * 2004-03-08 2006-01-26 Michael Barrett Implanted bronchial isolation devices and methods
US20060030863A1 (en) * 2004-07-21 2006-02-09 Fields Antony J Implanted bronchial isolation device delivery devices and methods
US20060032505A1 (en) * 2004-08-13 2006-02-16 Engineered Medical Systems, Inc. Perilaryngeal oral airway with multi-lumen esophogeal-obturator
EP1669095A1 (en) 2004-12-10 2006-06-14 Nitinol Development Corporation Collateral ventilation device with chest tube/evacuation features
US20060144398A1 (en) * 2004-12-08 2006-07-06 Rajiv Doshi Respiratory devices
US20060206147A1 (en) * 2002-02-21 2006-09-14 Devore Lauri J Intra-bronchial obstruction device that provides a medicant intra-bronchially to the patient
US20060235432A1 (en) * 2002-02-21 2006-10-19 Devore Lauri J Intra-bronchial obstructing device that controls biological interaction with the patient
US20060258904A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Feeding tube and track
US20060258902A1 (en) * 2005-05-13 2006-11-16 Spivey James T Apparatus useful for positioning a device on an endoscope
US20060258910A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Method of positioning a device on an endoscope
US20060258903A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Method of inserting a feeding tube
US20060258907A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Track for medical devices
US20070005083A1 (en) * 1997-04-30 2007-01-04 Sabaratham Sabanathan Occlusion device
EP1757322A1 (en) * 2005-08-23 2007-02-28 Nitinol Development Corporation Collateral ventilation bypass system with retention features
US20070063687A1 (en) * 2005-09-20 2007-03-22 Dacheng Zhou Circuit and method for bias voltage generation
US20070232992A1 (en) * 2006-03-31 2007-10-04 James Kutsko Articulable anchor
US20070235846A1 (en) * 2006-04-01 2007-10-11 Stats Chippac Ltd. Integrated circuit package system with net spacer
US20070293727A1 (en) * 2004-04-21 2007-12-20 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
EP1888156A2 (en) * 2005-05-13 2008-02-20 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US20080041373A1 (en) * 2006-06-07 2008-02-21 Ventus Medical, Inc. Nasal devices
US20080119693A1 (en) * 2004-04-21 2008-05-22 Acclarent, Inc. Methods and Apparatus for Treating Disorders of the Ear, Nose and Throat
US20080125626A1 (en) * 2004-04-21 2008-05-29 Acclarent, Inc. Devices, Systems and Methods Useable for Treating Sinusitis
US20080132938A1 (en) * 2004-04-21 2008-06-05 Acclarent, Inc. Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat
US20080178874A1 (en) * 2006-11-16 2008-07-31 Ventus Medical, Inc. Adjustable nasal devices
US20080287878A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Pulmonary visceral pleura anastomosis reinforcement
US20080287908A1 (en) * 2004-04-21 2008-11-20 Acclarent, Inc. Ethmoidotomy System and Implantable Spacer Devices Having Therapeutic Substance Delivery Capability for Treatment of Paranasal Sinusitis
US20090050144A1 (en) * 2004-12-08 2009-02-26 Ryan Kendall Pierce Adhesive nasal respiratory devices
US20090205651A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US7615005B2 (en) 2003-05-16 2009-11-10 Ethicon Endo-Surgery, Inc. Medical apparatus for use with an endoscope
US20090306544A1 (en) * 2008-06-09 2009-12-10 Ho-Kin Ng Instillation/aspiration device
US20090306545A1 (en) * 2008-06-09 2009-12-10 Mamdouh Elsakka Bronchoalveolar lavage catheter assembly
US20090301480A1 (en) * 2008-06-09 2009-12-10 Mamdouh Elsakka Diagnostic sample collection system and method of use
US20090318757A1 (en) * 2008-06-23 2009-12-24 Percuvision, Llc Flexible visually directed medical intubation instrument and method
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
US7686013B2 (en) 2006-01-17 2010-03-30 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve
US7753052B2 (en) 2003-06-05 2010-07-13 Portaero, Inc. Intra-thoracic collateral ventilation bypass system
US7766938B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Pleural effusion treatment device, method and material
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US7771472B2 (en) 2004-11-19 2010-08-10 Pulmonx Corporation Bronchial flow control devices and methods of use
US7789083B2 (en) 2003-05-20 2010-09-07 Portaero, Inc. Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US7806120B2 (en) 2004-12-08 2010-10-05 Ventus Medical, Inc. Nasal respiratory devices for positive end-expiratory pressure
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US7856979B2 (en) 2006-05-23 2010-12-28 Ventus Medical, Inc. Nasal respiratory devices
US20110017207A1 (en) * 2001-03-02 2011-01-27 Pulmonx Corporation Bronchial flow control devices with membrane seal
US7896008B2 (en) 2003-06-03 2011-03-01 Portaero, Inc. Lung reduction system
US20110060214A1 (en) * 2004-04-21 2011-03-10 Acclarent, Inc. Systems and Methods for Performing Image Guided Procedures Within the Ear, Nose, Throat and Paranasal Sinuses
US7905830B2 (en) 2005-05-13 2011-03-15 Ethicon Endo-Surgery, Inc. Sheath for use with an endoscope
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US20110112512A1 (en) * 2004-04-21 2011-05-12 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US8021385B2 (en) 2002-03-20 2011-09-20 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US8020700B2 (en) 2007-12-05 2011-09-20 Ventus Medical, Inc. Packaging and dispensing nasal devices
US20110226238A1 (en) * 2000-03-04 2011-09-22 Pulmonx Corporation Implanted bronchial isolation devices and methods
US20110251457A1 (en) * 2010-04-08 2011-10-13 Eric James Kezirian Endoscopic device and system
US8043301B2 (en) 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
US8062315B2 (en) * 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US8136230B2 (en) 2007-10-12 2012-03-20 Spiration, Inc. Valve loader method, system, and apparatus
US8142455B2 (en) 2006-03-13 2012-03-27 Pneumrx, Inc. Delivery of minimally invasive lung volume reduction devices
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US20140081252A1 (en) * 2012-09-14 2014-03-20 The Spectranetics Corporation Tissue slitting methods and systems
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US8721734B2 (en) 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US8721591B2 (en) 2004-04-21 2014-05-13 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US8740921B2 (en) 2006-03-13 2014-06-03 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
US20140275777A1 (en) * 2013-03-15 2014-09-18 Erhan H. Gunday Resector Balloon Catheter With Multi-Port Hub
US8870893B2 (en) 2004-04-21 2014-10-28 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US8875711B2 (en) 2010-05-27 2014-11-04 Theravent, Inc. Layered nasal respiratory devices
US8876791B2 (en) 2005-02-25 2014-11-04 Pulmonx Corporation Collateral pathway treatment using agent entrained by aspiration flow current
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US9107574B2 (en) 2004-04-21 2015-08-18 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US9125639B2 (en) 2004-11-23 2015-09-08 Pneumrx, Inc. Steerable device for accessing a target site and methods
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
US9211181B2 (en) 2004-11-19 2015-12-15 Pulmonx Corporation Implant loading device and system
US9308361B2 (en) 2005-01-18 2016-04-12 Acclarent, Inc. Implantable devices and methods for treating sinusitis and other disorders
CN105536081A (en) * 2016-01-22 2016-05-04 长江大学 Full-automatic body cavity effusion and pneumatosis extraction instrument
US9358150B2 (en) 2005-05-13 2016-06-07 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US9468362B2 (en) 2004-04-21 2016-10-18 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20170135560A1 (en) * 2015-11-18 2017-05-18 Art Healthcare Ltd. Sheath and hub for imaging endoscope
US9737195B2 (en) 2013-03-15 2017-08-22 Sanovas, Inc. Handheld resector balloon system
US20170258983A1 (en) * 2016-03-11 2017-09-14 Hans Utz Illuminated medical infusion
US20170311792A1 (en) * 2010-10-18 2017-11-02 Erhan H. Gunday Anchored Working Channel
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US9826999B2 (en) 2004-04-21 2017-11-28 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US9833354B2 (en) 2004-12-08 2017-12-05 Theravent, Inc. Nasal respiratory devices
US10076441B2 (en) 2009-06-19 2018-09-18 Braincool Ab Devices for cooling the nasal cavity
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
CN109498966A (en) * 2019-01-11 2019-03-22 上海市肺科医院 Bronchogenic tuberculosis auxiliary therapeutic apparatus under a kind of airway wall
US10362927B2 (en) * 2013-02-01 2019-07-30 Deka Products Limited Partnership Endoscope with pannable camera
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US10610228B2 (en) 2004-12-08 2020-04-07 Theravent, Inc. Passive nasal peep devices
US10624733B2 (en) 2015-03-24 2020-04-21 Spiration, Inc. Airway stent
US10639452B2 (en) 2006-07-13 2020-05-05 Best Medical International, Inc. Echo-opaque urethral catheter
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
WO2021011408A1 (en) 2019-07-12 2021-01-21 Bard Access Systems, Inc. Tubing with integrated optical fiber, medical devices, and methods thereof
US11529502B2 (en) 2004-04-21 2022-12-20 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US11957318B2 (en) 2021-04-29 2024-04-16 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8016823B2 (en) 2003-01-18 2011-09-13 Tsunami Medtech, Llc Medical instrument and method of use
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US20060135947A1 (en) 2000-10-27 2006-06-22 Pulmonx Occlusal stent and methods for its use
US9433457B2 (en) 2000-12-09 2016-09-06 Tsunami Medtech, Llc Medical instruments and techniques for thermally-mediated therapies
US7549987B2 (en) 2000-12-09 2009-06-23 Tsunami Medtech, Llc Thermotherapy device
US6609521B1 (en) * 2001-04-09 2003-08-26 Regents Of The University Of Minnesota Endotracheal tube
JP4409123B2 (en) * 2001-07-19 2010-02-03 オリンパス株式会社 Medical obturator
US7883471B2 (en) * 2001-09-10 2011-02-08 Pulmonx Corporation Minimally invasive determination of collateral ventilation in lungs
US8444636B2 (en) 2001-12-07 2013-05-21 Tsunami Medtech, Llc Medical instrument and method of use
DE10321990B4 (en) * 2003-05-15 2005-10-13 Microcuff Gmbh Trachealbeatmungungsvorrichtung
US20040236279A1 (en) * 2003-05-22 2004-11-25 Atrium Medical Corp. Gaseous therapeutic agent delivery
US7533667B2 (en) 2003-05-29 2009-05-19 Portaero, Inc. Methods and devices to assist pulmonary decompression
US9301829B2 (en) * 2003-07-30 2016-04-05 Boston Scientific Scimed, Inc. Embolic protection aspirator
US8579892B2 (en) 2003-10-07 2013-11-12 Tsunami Medtech, Llc Medical system and method of use
AU2005206767B2 (en) * 2004-01-09 2009-09-17 Corazon Technologies, Inc. Multilumen catheters and methods for their use
US20060047291A1 (en) * 2004-08-20 2006-03-02 Uptake Medical Corporation Non-foreign occlusion of an airway and lung collapse
US20060162731A1 (en) 2004-11-16 2006-07-27 Pulmonx Pulmonary occlusal stent delivery catheter, loading system and methods of use
JP5020824B2 (en) * 2004-11-16 2012-09-05 ロバート・エル・バリー Lung therapy apparatus and method
US7398782B2 (en) 2004-11-19 2008-07-15 Portaero, Inc. Method for pulmonary drug delivery
US8496006B2 (en) * 2005-01-20 2013-07-30 Pulmonx Corporation Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US20080228137A1 (en) 2007-03-12 2008-09-18 Pulmonx Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US11883029B2 (en) 2005-01-20 2024-01-30 Pulmonx Corporation Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US20070032785A1 (en) 2005-08-03 2007-02-08 Jennifer Diederich Tissue evacuation device
US8523782B2 (en) 2005-12-07 2013-09-03 Pulmonx Corporation Minimally invasive determination of collateral ventilation in lungs
US7993323B2 (en) 2006-11-13 2011-08-09 Uptake Medical Corp. High pressure and high temperature vapor catheters and systems
US8585645B2 (en) * 2006-11-13 2013-11-19 Uptake Medical Corp. Treatment with high temperature vapor
DE102006057809A1 (en) 2006-12-06 2008-06-12 Ruprecht-Karls-Universität Heidelberg intubation tube
US20080221582A1 (en) * 2007-03-05 2008-09-11 Pulmonx Pulmonary stent removal device
US8100959B2 (en) * 2007-03-09 2012-01-24 Pulmonx Corporation Loading device for a pulmonary implant
US8137302B2 (en) * 2007-03-12 2012-03-20 Pulmonx Corporation Methods and systems for occluding collateral flow channels in the lung
US8216217B2 (en) 2007-08-23 2012-07-10 Aegea Medical, Inc. Uterine therapy device and method
US8147532B2 (en) * 2007-10-22 2012-04-03 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US8322335B2 (en) * 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US9924992B2 (en) 2008-02-20 2018-03-27 Tsunami Medtech, Llc Medical system and method of use
US8721632B2 (en) 2008-09-09 2014-05-13 Tsunami Medtech, Llc Methods for delivering energy into a target tissue of a body
US8579888B2 (en) 2008-06-17 2013-11-12 Tsunami Medtech, Llc Medical probes for the treatment of blood vessels
US20100036361A1 (en) * 2008-06-20 2010-02-11 Pulmonx System and method for delivering multiple implants into lung passageways
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US9700365B2 (en) 2008-10-06 2017-07-11 Santa Anna Tech Llc Method and apparatus for the ablation of gastrointestinal tissue
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US11284931B2 (en) 2009-02-03 2022-03-29 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
DK2393538T3 (en) 2009-02-06 2017-11-27 Endoclear Llc Devices for cleaning endotracheal tubes
US8468637B2 (en) 2009-02-06 2013-06-25 Endoclear Llc Mechanically-actuated endotracheal tube cleaning device
FR2945954A1 (en) * 2009-05-27 2010-12-03 Dioptik Intubation probe for introduction into trachea of patient during anesthesia and nasal intubation, has internal tube inserted into external tube, where surfaces of respective tubes define receiving housing of ducts
US8900223B2 (en) 2009-11-06 2014-12-02 Tsunami Medtech, Llc Tissue ablation systems and methods of use
US9161801B2 (en) 2009-12-30 2015-10-20 Tsunami Medtech, Llc Medical system and method of use
EP2902066B1 (en) 2010-03-29 2021-03-10 Endoclear LLC Airway cleaning and visualization
US9943353B2 (en) 2013-03-15 2018-04-17 Tsunami Medtech, Llc Medical system and method of use
US20120095369A1 (en) 2010-10-15 2012-04-19 Teixeira Scott M System and Method for Sampling Device for Bodily Fluids
WO2012064864A1 (en) 2010-11-09 2012-05-18 Aegea Medical Inc. Positioning method and apparatus for delivering vapor to the uterus
US9662060B2 (en) 2011-10-07 2017-05-30 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
WO2013063520A1 (en) 2011-10-27 2013-05-02 Endoclear, Llc Endotracheal tube coupling adapters
WO2014055675A1 (en) 2012-10-02 2014-04-10 Lutz Freitag Devices and methods for pulmonary diagnosis
EP2928517B1 (en) 2012-12-04 2021-02-17 Endoclear LLC Suction cleaning devices
WO2014113724A2 (en) 2013-01-17 2014-07-24 Sharma Virender K Method and apparatus for tissue ablation
US9434977B2 (en) 2013-02-27 2016-09-06 Avent, Inc. Rapid identification of organisms in bodily fluids
US8668654B1 (en) 2013-03-13 2014-03-11 Sanovas, Inc. Cytological brushing system
US9782211B2 (en) 2013-10-01 2017-10-10 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
US10034986B2 (en) * 2013-11-11 2018-07-31 Crossbay Medical, Inc. Method and apparatus of tubal patency catheter and delivery systems
US10245074B2 (en) 2013-11-11 2019-04-02 Crossbay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
US9101391B2 (en) 2013-11-11 2015-08-11 Cross Bay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
US10099027B2 (en) 2014-01-24 2018-10-16 Cole Research & Design Oral suction device
US10179019B2 (en) 2014-05-22 2019-01-15 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
EP3145425A4 (en) 2014-05-22 2018-02-14 Aegea Medical, Inc. Systems and methods for performing endometrial ablation
EP3151898B1 (en) 2014-06-03 2021-03-24 Endoclear LLC Cleaning devices, systems and methods
US10485604B2 (en) 2014-12-02 2019-11-26 Uptake Medical Technology Inc. Vapor treatment of lung nodules and tumors
US10531906B2 (en) 2015-02-02 2020-01-14 Uptake Medical Technology Inc. Medical vapor generator
US20160331343A1 (en) 2015-05-11 2016-11-17 Veran Medical Technologies, Inc. Medical apparatus with translatable imaging device for real-time confirmation of interception of target tissue
ITUB20160135A1 (en) * 2016-01-15 2017-07-15 Angiodroid S R L A Socio Unico ANGIOGRAPHIC INTRODUCTION DEVICE WITH OCCLUSIVE BALL FOR COMPLEX ENDOVASCULAR INTERVENTIONS
EP3416551B1 (en) 2016-02-19 2022-10-12 Aegea Medical Inc. Apparatus for determining the integrity of a bodily cavity
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
US11419490B2 (en) * 2016-08-02 2022-08-23 Covidien Lp System and method of using an endoscopic catheter as a port in laparoscopic surgery
US10448886B2 (en) 2016-08-17 2019-10-22 Covidien Lp Induced atelectasis and pulmonary consolidation systems and methods
US10799092B2 (en) 2016-09-19 2020-10-13 Covidien Lp System and method for cleansing segments of a luminal network
CA3038246A1 (en) 2016-09-30 2018-04-05 Pneumrx Inc. Guidewire
US11510646B2 (en) * 2017-04-05 2022-11-29 Bk Medical Aps Ultrasound imaging system probe cable and connector
US11129673B2 (en) 2017-05-05 2021-09-28 Uptake Medical Technology Inc. Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD
US11141308B2 (en) 2017-08-31 2021-10-12 Crossbay Medical, Inc. Apparatus and method for everting catheter for IUD delivery and placement in the uterine cavity
US11344364B2 (en) 2017-09-07 2022-05-31 Uptake Medical Technology Inc. Screening method for a target nerve to ablate for the treatment of inflammatory lung disease
US11350988B2 (en) 2017-09-11 2022-06-07 Uptake Medical Technology Inc. Bronchoscopic multimodality lung tumor treatment
USD845467S1 (en) 2017-09-17 2019-04-09 Uptake Medical Technology Inc. Hand-piece for medical ablation catheter
US11419658B2 (en) 2017-11-06 2022-08-23 Uptake Medical Technology Inc. Method for treating emphysema with condensable thermal vapor
CN107802946A (en) * 2017-11-13 2018-03-16 北京大学第医院 A kind of bronchoscope foley's tube component
US11490946B2 (en) 2017-12-13 2022-11-08 Uptake Medical Technology Inc. Vapor ablation handpiece
WO2019232432A1 (en) 2018-06-01 2019-12-05 Santa Anna Tech Llc Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems
US11653927B2 (en) 2019-02-18 2023-05-23 Uptake Medical Technology Inc. Vapor ablation treatment of obstructive lung disease
CN109847139B (en) * 2019-03-07 2020-01-14 谢晴晴 Intelligent lung breathing lavage device
US11717656B2 (en) * 2019-03-20 2023-08-08 Gyros ACMI Inc. Delivery of mixed phase media for the treatment of the anatomy
CN112843436A (en) * 2020-02-16 2021-05-28 东莞天天向上医疗科技有限公司 Multifunctional balloon dilatation catheter for in vivo pulmonary membrane oxygenation and use method
WO2021219659A1 (en) * 2020-04-28 2021-11-04 Carag Ag Device for treating lung diseases
EP3932457A1 (en) * 2020-07-02 2022-01-05 Carag AG Tracheal catheter, intubation hose and treatment device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6010740B2 (en) 1981-05-07 1985-03-19 宏司 井上 Endotracheal tube for unilateral lung ventilation
US4714460A (en) * 1983-07-29 1987-12-22 Reynaldo Calderon Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency
US4716896A (en) 1986-08-01 1988-01-05 Ackrad Laboratories Bronchial catheter
US5207220A (en) 1989-12-12 1993-05-04 Burroughs Wellcome Co. Method for administering pharmaceuticals, including liquid surfactant, to the lungs
US5246012A (en) 1990-12-21 1993-09-21 Ballard Medical Products Bronchoalveolar lavage catheter
US5285778A (en) 1991-04-19 1994-02-15 Mackin Robert A Endotracheal tube wih fibers optic illumination and viewing and auxiliary tube
US5660175A (en) 1995-08-21 1997-08-26 Dayal; Bimal Endotracheal device
US5653231A (en) 1995-11-28 1997-08-05 Medcare Medical Group, Inc. Tracheostomy length single use suction catheter

Cited By (340)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670373B1 (en) 1997-04-30 2010-03-02 Pulmonx Corporation Occlusion device
US8136520B2 (en) 1997-04-30 2012-03-20 Pulmonx Corporation Occlusion device
US20070005083A1 (en) * 1997-04-30 2007-01-04 Sabaratham Sabanathan Occlusion device
US20020095209A1 (en) * 1997-09-16 2002-07-18 Gholam-Reza Zadno-Azizi Body fluid flow control device
US20030199972A1 (en) * 1997-09-16 2003-10-23 Gholam-Reza Zadno-Azizi Body fluid flow control device
US20030212452A1 (en) * 1997-09-16 2003-11-13 Gholam-Reza Zadno-Azizi Body fluid flow control device
US6997189B2 (en) 1998-06-05 2006-02-14 Broncus Technologies, Inc. Method for lung volume reduction
US20040078054A1 (en) * 1998-06-05 2004-04-22 Broncus Technologies, Inc. Method for lung volume reduction
US20040134487A1 (en) * 2000-03-04 2004-07-15 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US8357139B2 (en) 2000-03-04 2013-01-22 Pulmonx Corporation Methods and devices for use in performing pulmonary procedures
US20110226238A1 (en) * 2000-03-04 2011-09-22 Pulmonx Corporation Implanted bronchial isolation devices and methods
US6679264B1 (en) 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US8474460B2 (en) 2000-03-04 2013-07-02 Pulmonx Corporation Implanted bronchial isolation devices and methods
US6694979B2 (en) 2000-03-04 2004-02-24 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US20060174870A1 (en) * 2000-03-04 2006-08-10 Deem Mark E Methods and devices for use in performing pulmonary procedures
US7662181B2 (en) 2000-03-04 2010-02-16 Pulmonx Corporation Methods and devices for use in performing pulmonary procedures
US20050051163A1 (en) * 2000-03-04 2005-03-10 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US20080173309A1 (en) * 2000-06-16 2008-07-24 Rajiv Doshi Methods and devices for improving breathing in patients with pulmonary disease
US20060032497A1 (en) * 2000-06-16 2006-02-16 Rajiv Doshi Methods and devices for improving breathing in patients with pulmonary disease
US6722360B2 (en) 2000-06-16 2004-04-20 Rajiv Doshi Methods and devices for improving breathing in patients with pulmonary disease
US7992563B2 (en) 2000-06-16 2011-08-09 Ventus Medical, Inc. Methods and devices for improving breathing in patients with pulmonary disease
US7334581B2 (en) 2000-06-16 2008-02-26 Ventus Medical, Inc. Methods and devices for improving breathing in patients with pulmonary disease
US8707955B2 (en) 2000-06-16 2014-04-29 Theravent, Inc. Methods and devices for improving breathing in patients with pulmonary disease
US20020112729A1 (en) * 2001-02-21 2002-08-22 Spiration, Inc. Intra-bronchial obstructing device that controls biological interaction with the patient
US8251067B2 (en) 2001-03-02 2012-08-28 Pulmonx Corporation Bronchial flow control devices with membrane seal
US20040074491A1 (en) * 2001-03-02 2004-04-22 Michael Hendricksen Delivery methods and devices for implantable bronchial isolation devices
US20040060563A1 (en) * 2001-03-02 2004-04-01 Alan Rapacki Bronchial flow control devices and methods of use
US7798147B2 (en) 2001-03-02 2010-09-21 Pulmonx Corporation Bronchial flow control devices with membrane seal
US20040055606A1 (en) * 2001-03-02 2004-03-25 Emphasys Medical, Inc. Bronchial flow control devices with membrane seal
US20110017207A1 (en) * 2001-03-02 2011-01-27 Pulmonx Corporation Bronchial flow control devices with membrane seal
US20040206349A1 (en) * 2001-09-11 2004-10-21 Alferness Clifton A. Removable lung reduction devices, systems, and methods
US20040211412A1 (en) * 2001-09-11 2004-10-28 Alferness Clifton A. Removable lung reduction devices, systems, and method
US7757692B2 (en) 2001-09-11 2010-07-20 Spiration, Inc. Removable lung reduction devices, systems, and methods
US8974484B2 (en) 2001-09-11 2015-03-10 Spiration, Inc. Removable lung reduction devices, systems, and methods
US8414655B2 (en) 2001-09-11 2013-04-09 Spiration, Inc. Removable lung reduction devices, systems, and methods
US7854228B2 (en) 2001-10-11 2010-12-21 Pulmonx Corporation Bronchial flow control devices and methods of use
US20030070682A1 (en) * 2001-10-11 2003-04-17 Wilson Peter M. Bronchial flow control devices and methods of use
US20050166925A1 (en) * 2001-10-11 2005-08-04 Emphasys Medical, Inc., A California Corporation Bronchial flow control devices and methods of use
US20050145253A1 (en) * 2001-10-11 2005-07-07 Emphasys Medical, Inc., A Delaware Corporation Bronchial flow control devices and methods of use
US7896887B2 (en) 2001-10-25 2011-03-01 Spiration, Inc. Apparatus and method for deployment of a bronchial obstruction device
US20070185531A1 (en) * 2001-10-25 2007-08-09 Spiration, Inc. Apparatus and method for deployment of a bronchial obstruction device
US20030183235A1 (en) * 2001-10-25 2003-10-02 Spiration, Inc. Bronchial obstruction device deployment system and method
US8986336B2 (en) 2001-10-25 2015-03-24 Spiration, Inc. Apparatus and method for deployment of a bronchial obstruction device
US7942931B2 (en) 2002-02-21 2011-05-17 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20060206147A1 (en) * 2002-02-21 2006-09-14 Devore Lauri J Intra-bronchial obstruction device that provides a medicant intra-bronchially to the patient
US20030158515A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20060200076A1 (en) * 2002-02-21 2006-09-07 Gonzalez Hugo X Device and method for intra-bronchial provision of a therapeutic agent
US20060235432A1 (en) * 2002-02-21 2006-10-19 Devore Lauri J Intra-bronchial obstructing device that controls biological interaction with the patient
US20030228344A1 (en) * 2002-03-08 2003-12-11 Fields Antony J. Methods and devices for inducing collapse in lung regions fed by collateral pathways
US20080249503A1 (en) * 2002-03-08 2008-10-09 Fields Antony J Methods and devices for lung treatment
US20060283462A1 (en) * 2002-03-08 2006-12-21 Fields Antony J Methods and devices for inducing collapse in lung regions fed by collateral pathways
US8926647B2 (en) 2002-03-20 2015-01-06 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US8177805B2 (en) 2002-03-20 2012-05-15 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US8021385B2 (en) 2002-03-20 2011-09-20 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20030195385A1 (en) * 2002-04-16 2003-10-16 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20060235467A1 (en) * 2002-04-16 2006-10-19 Devore Lauri J Removable anchored lung volume reduction device and methods
US20030212412A1 (en) * 2002-05-09 2003-11-13 Spiration, Inc. Intra-bronchial obstructing device that permits mucus transport
US7842061B2 (en) 2002-05-17 2010-11-30 Spiration, Inc. Methods of achieving lung volume reduction with removable anchored devices
US7875048B2 (en) 2002-05-17 2011-01-25 Spiration, Inc. One-way valve devices for anchored implantation in a lung
US20030216769A1 (en) * 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US8257381B2 (en) 2002-05-17 2012-09-04 Spiration, Inc. One-way valve devices for anchored implantation in a lung
US8956319B2 (en) 2002-05-17 2015-02-17 Spiration, Inc. One-way valve devices for anchored implantation in a lung
US20050033344A1 (en) * 2002-05-17 2005-02-10 Dillard David H. One-way valve devices for anchored implantation in a lung
US20040039250A1 (en) * 2002-05-28 2004-02-26 David Tholfsen Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment
US20050066974A1 (en) * 2002-05-28 2005-03-31 Antony Fields Modification of lung region flow dynamics using flow control devices implanted in bronchial wall channels
US20060076023A1 (en) * 2002-07-26 2006-04-13 Emphasys Medical, Inc., A Delaware Corporation Bronchial flow control devices and methods of use
EP1386635A1 (en) * 2002-07-31 2004-02-04 Cordis Corporation Long term oxygen therapy system
US7086398B2 (en) 2002-07-31 2006-08-08 Cordis Corporation Long term oxygen therapy system
US7717115B2 (en) 2002-11-27 2010-05-18 Pulmonx Corporation Delivery methods and devices for implantable bronchial isolation devices
US20040148035A1 (en) * 2002-11-27 2004-07-29 Michael Barrett Delivery methods and devices for implantable bronchial isolation devices
US7814912B2 (en) 2002-11-27 2010-10-19 Pulmonx Corporation Delivery methods and devices for implantable bronchial isolation devices
US20060004305A1 (en) * 2002-11-27 2006-01-05 George Robert M Delivery methods and devices for implantable bronchial isolation devices
WO2004064885A3 (en) * 2003-01-20 2004-10-21 Pulmonx Methods and arrangement for reducing the volume of the lung
US20050061322A1 (en) * 2003-01-20 2005-03-24 Pulmonx Method and arrangement for reducing the volume of a lung
US20040210248A1 (en) * 2003-03-12 2004-10-21 Spiration, Inc. Apparatus, method and assembly for delivery of intra-bronchial devices
US8667973B2 (en) 2003-04-08 2014-03-11 Spiration, Inc. Bronchoscopic lung volume reduction method
US8079368B2 (en) 2003-04-08 2011-12-20 Spiration, Inc. Bronchoscopic lung volume reduction method
US20060249164A1 (en) * 2003-04-08 2006-11-09 Springmeyer Steven C Bronchoscopic lung volume reduction method
US20040200484A1 (en) * 2003-04-08 2004-10-14 Springmeyer Steven C. Bronchoscopic lung volume reduction method
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US8029492B2 (en) 2003-05-07 2011-10-04 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US7828789B2 (en) 2003-05-07 2010-11-09 Portaero, Inc. Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US20050203400A1 (en) * 2003-05-10 2005-09-15 Zappala Stephen M. System and method for precisely identifying a configuration of an anatomical space in real time
US7615005B2 (en) 2003-05-16 2009-11-10 Ethicon Endo-Surgery, Inc. Medical apparatus for use with an endoscope
US7789083B2 (en) 2003-05-20 2010-09-07 Portaero, Inc. Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US20040243393A1 (en) * 2003-05-29 2004-12-02 Microsoft Corporation Semantic object synchronous understanding implemented with speech application language tags
US7896008B2 (en) 2003-06-03 2011-03-01 Portaero, Inc. Lung reduction system
US7753052B2 (en) 2003-06-05 2010-07-13 Portaero, Inc. Intra-thoracic collateral ventilation bypass system
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
US8323230B2 (en) 2003-07-15 2012-12-04 Portaero, Inc. Methods and devices to accelerate wound healing in thoracic anastomosis applications
US7887585B2 (en) 2003-08-08 2011-02-15 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US20050137714A1 (en) * 2003-08-08 2005-06-23 Gonzalez Hugo X. Bronchoscopic repair of air leaks in a lung
US9622752B2 (en) 2003-08-08 2017-04-18 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US20110208228A1 (en) * 2003-08-08 2011-08-25 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US20090182369A1 (en) * 2003-08-08 2009-07-16 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US8974527B2 (en) 2003-08-08 2015-03-10 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US8444690B2 (en) 2003-08-08 2013-05-21 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US20050178389A1 (en) * 2004-01-27 2005-08-18 Shaw David P. Disease indications for selective endobronchial lung region isolation
US20090255537A1 (en) * 2004-01-27 2009-10-15 Pulmonx Disease indications for selective endobronchial lung region isolation
US8206684B2 (en) 2004-02-27 2012-06-26 Pulmonx Corporation Methods and devices for blocking flow through collateral pathways in the lung
US20050196344A1 (en) * 2004-02-27 2005-09-08 Mccutcheon John Methods and devices for blocking flow through collateral pathways in the lung
US7585276B2 (en) * 2004-03-01 2009-09-08 Fujinon Corporation Endoscope system and operation method for endoscope
US20090287051A1 (en) * 2004-03-01 2009-11-19 Fujinon Corporation Endoscope system and operation method for endoscope
US20050222500A1 (en) * 2004-03-01 2005-10-06 Fujinon Corporation Endoscope system and operation method for endoscope
US20060020347A1 (en) * 2004-03-08 2006-01-26 Michael Barrett Implanted bronchial isolation devices and methods
US20080132938A1 (en) * 2004-04-21 2008-06-05 Acclarent, Inc. Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat
US8870893B2 (en) 2004-04-21 2014-10-28 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US10702295B2 (en) 2004-04-21 2020-07-07 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US10695080B2 (en) 2004-04-21 2020-06-30 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US9370649B2 (en) 2004-04-21 2016-06-21 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US8864787B2 (en) 2004-04-21 2014-10-21 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US9265407B2 (en) 2004-04-21 2016-02-23 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US11529502B2 (en) 2004-04-21 2022-12-20 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US8858586B2 (en) 2004-04-21 2014-10-14 Acclarent, Inc. Methods for enlarging ostia of paranasal sinuses
US11511090B2 (en) 2004-04-21 2022-11-29 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US8852143B2 (en) 2004-04-21 2014-10-07 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US11202644B2 (en) 2004-04-21 2021-12-21 Acclarent, Inc. Shapeable guide catheters and related methods
US8828041B2 (en) 2004-04-21 2014-09-09 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US11065061B2 (en) 2004-04-21 2021-07-20 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US11589742B2 (en) 2004-04-21 2023-02-28 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US8777926B2 (en) 2004-04-21 2014-07-15 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasel or paranasal structures
US11019989B2 (en) 2004-04-21 2021-06-01 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US8961398B2 (en) * 2004-04-21 2015-02-24 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US11020136B2 (en) 2004-04-21 2021-06-01 Acclarent, Inc. Deflectable guide catheters and related methods
US8764709B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US20080287908A1 (en) * 2004-04-21 2008-11-20 Acclarent, Inc. Ethmoidotomy System and Implantable Spacer Devices Having Therapeutic Substance Delivery Capability for Treatment of Paranasal Sinusitis
US10874838B2 (en) 2004-04-21 2020-12-29 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US10856727B2 (en) 2004-04-21 2020-12-08 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20110060214A1 (en) * 2004-04-21 2011-03-10 Acclarent, Inc. Systems and Methods for Performing Image Guided Procedures Within the Ear, Nose, Throat and Paranasal Sinuses
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US8764726B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US10806477B2 (en) 2004-04-21 2020-10-20 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US10779752B2 (en) 2004-04-21 2020-09-22 Acclarent, Inc. Guidewires for performing image guided procedures
US20110112512A1 (en) * 2004-04-21 2011-05-12 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US9468362B2 (en) 2004-04-21 2016-10-18 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US20100042046A1 (en) * 2004-04-21 2010-02-18 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US20080125626A1 (en) * 2004-04-21 2008-05-29 Acclarent, Inc. Devices, Systems and Methods Useable for Treating Sinusitis
US20080119693A1 (en) * 2004-04-21 2008-05-22 Acclarent, Inc. Methods and Apparatus for Treating Disorders of the Ear, Nose and Throat
US10631756B2 (en) 2004-04-21 2020-04-28 Acclarent, Inc. Guidewires for performing image guided procedures
US8961495B2 (en) 2004-04-21 2015-02-24 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US8721591B2 (en) 2004-04-21 2014-05-13 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US9610428B2 (en) 2004-04-21 2017-04-04 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US20070293727A1 (en) * 2004-04-21 2007-12-20 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US10500380B2 (en) 2004-04-21 2019-12-10 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US10492810B2 (en) 2004-04-21 2019-12-03 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US8715169B2 (en) 2004-04-21 2014-05-06 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US10441758B2 (en) 2004-04-21 2019-10-15 Acclarent, Inc. Frontal sinus spacer
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US9241834B2 (en) 2004-04-21 2016-01-26 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US10098652B2 (en) 2004-04-21 2018-10-16 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US10034682B2 (en) 2004-04-21 2018-07-31 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US9220879B2 (en) 2004-04-21 2015-12-29 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US9055965B2 (en) 2004-04-21 2015-06-16 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US9826999B2 (en) 2004-04-21 2017-11-28 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US9107574B2 (en) 2004-04-21 2015-08-18 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8905922B2 (en) 2004-04-21 2014-12-09 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US9814379B2 (en) 2004-04-21 2017-11-14 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US9167961B2 (en) 2004-04-21 2015-10-27 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US9649477B2 (en) 2004-04-21 2017-05-16 Acclarent, Inc. Frontal sinus spacer
US11864725B2 (en) 2004-04-21 2024-01-09 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
US7775968B2 (en) 2004-06-14 2010-08-17 Pneumrx, Inc. Guided access to lung tissues
US20060009748A1 (en) * 2004-06-16 2006-01-12 Mathis Mark L Method of compressing a portion of a lung
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US7766938B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Pleural effusion treatment device, method and material
US20060030863A1 (en) * 2004-07-21 2006-02-09 Fields Antony J Implanted bronchial isolation device delivery devices and methods
US20060032505A1 (en) * 2004-08-13 2006-02-16 Engineered Medical Systems, Inc. Perilaryngeal oral airway with multi-lumen esophogeal-obturator
US7013899B2 (en) 2004-08-13 2006-03-21 Engineered Medical System, Inc. Perilaryngeal oral airway with multi-lumen esophogeal-obturator
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US7771472B2 (en) 2004-11-19 2010-08-10 Pulmonx Corporation Bronchial flow control devices and methods of use
US11083556B2 (en) 2004-11-19 2021-08-10 Pulmonx Corporation Implant loading device and system
US9872755B2 (en) 2004-11-19 2018-01-23 Pulmonx Corporation Implant loading device and system
US9211181B2 (en) 2004-11-19 2015-12-15 Pulmonx Corporation Implant loading device and system
US8388682B2 (en) 2004-11-19 2013-03-05 Pulmonx Corporation Bronchial flow control devices and methods of use
US10034999B2 (en) 2004-11-23 2018-07-31 Pneumrx, Inc. Steerable device for accessing a target site and methods
US9125639B2 (en) 2004-11-23 2015-09-08 Pneumrx, Inc. Steerable device for accessing a target site and methods
US20060150979A1 (en) * 2004-12-08 2006-07-13 Ventus Medical, Inc. Nasal respiratory devices
US7735492B2 (en) 2004-12-08 2010-06-15 Ventus Medical, Inc. Nasal respiratory devices
US20060150978A1 (en) * 2004-12-08 2006-07-13 Ventus Medical, Inc. Methods of treating respiratory disorders
US8291909B2 (en) 2004-12-08 2012-10-23 Ventus Medical, Inc. Methods of treating a disorder by inhibiting expiration
US20100147308A1 (en) * 2004-12-08 2010-06-17 Rajiv Doshi Respiratory devices
US9238113B2 (en) 2004-12-08 2016-01-19 Theravent, Inc. Nasal respiratory devices for positive end-expiratory pressure
US7992564B2 (en) 2004-12-08 2011-08-09 Ventus Medical, Inc. Respiratory devices
US10610228B2 (en) 2004-12-08 2020-04-07 Theravent, Inc. Passive nasal peep devices
US8302606B2 (en) 2004-12-08 2012-11-06 Ventus Medical, Inc. Methods of treating a sleeping subject
US8235046B2 (en) 2004-12-08 2012-08-07 Ventus Medical, Inc. Nasal devices for use while sleeping
US8365736B2 (en) 2004-12-08 2013-02-05 Ventus Medical, Inc. Nasal devices with respiratory gas source
US8215308B2 (en) 2004-12-08 2012-07-10 Ventus Medical, Inc. Sealing nasal devices for use while sleeping
US7798148B2 (en) 2004-12-08 2010-09-21 Ventus Medical, Inc. Respiratory devices
US9833354B2 (en) 2004-12-08 2017-12-05 Theravent, Inc. Nasal respiratory devices
US7735491B2 (en) 2004-12-08 2010-06-15 Ventus Medical, Inc. Methods of treating respiratory disorders
US20060144398A1 (en) * 2004-12-08 2006-07-06 Rajiv Doshi Respiratory devices
US20090050144A1 (en) * 2004-12-08 2009-02-26 Ryan Kendall Pierce Adhesive nasal respiratory devices
US7806120B2 (en) 2004-12-08 2010-10-05 Ventus Medical, Inc. Nasal respiratory devices for positive end-expiratory pressure
US8302607B2 (en) 2004-12-08 2012-11-06 Ventus Medical, Inc. Adhesive nasal respiratory devices
US8061357B2 (en) 2004-12-08 2011-11-22 Ventus Medical, Inc. Adhesive nasal respiratory devices
EP1669095A1 (en) 2004-12-10 2006-06-14 Nitinol Development Corporation Collateral ventilation device with chest tube/evacuation features
US7824366B2 (en) 2004-12-10 2010-11-02 Portaero, Inc. Collateral ventilation device with chest tube/evacuation features and method
US9308361B2 (en) 2005-01-18 2016-04-12 Acclarent, Inc. Implantable devices and methods for treating sinusitis and other disorders
US8876791B2 (en) 2005-02-25 2014-11-04 Pulmonx Corporation Collateral pathway treatment using agent entrained by aspiration flow current
US7857754B2 (en) * 2005-05-13 2010-12-28 Ethicon Endo-Surgery, Inc. Apparatus useful for positioning a device on an endoscope
US7648457B2 (en) 2005-05-13 2010-01-19 Ethicon Endo-Surgery, Inc. Method of positioning a device on an endoscope
US9358150B2 (en) 2005-05-13 2016-06-07 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
US7905830B2 (en) 2005-05-13 2011-03-15 Ethicon Endo-Surgery, Inc. Sheath for use with an endoscope
EP1888156A2 (en) * 2005-05-13 2008-02-20 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US20060258910A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Method of positioning a device on an endoscope
US7615003B2 (en) 2005-05-13 2009-11-10 Ethicon Endo-Surgery, Inc. Track for medical devices
US20060258902A1 (en) * 2005-05-13 2006-11-16 Spivey James T Apparatus useful for positioning a device on an endoscope
EP1888156A4 (en) * 2005-05-13 2014-04-09 Benechill Inc Methods and devices for non-invasive cerebral and systemic cooling
US20060258904A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Feeding tube and track
US20060258903A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Method of inserting a feeding tube
US10561527B2 (en) * 2005-05-13 2020-02-18 Braincool Ab Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
US20060258907A1 (en) * 2005-05-13 2006-11-16 David Stefanchik Track for medical devices
US10124154B2 (en) 2005-06-10 2018-11-13 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US10842978B2 (en) 2005-06-10 2020-11-24 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
EP1757322A1 (en) * 2005-08-23 2007-02-28 Nitinol Development Corporation Collateral ventilation bypass system with retention features
US8104474B2 (en) * 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
US20070063687A1 (en) * 2005-09-20 2007-03-22 Dacheng Zhou Circuit and method for bias voltage generation
US7726305B2 (en) 2006-01-17 2010-06-01 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve
US7686013B2 (en) 2006-01-17 2010-03-30 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve
US8668707B2 (en) 2006-03-13 2014-03-11 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9782558B2 (en) 2006-03-13 2017-10-10 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US10188397B2 (en) 2006-03-13 2019-01-29 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US8282660B2 (en) 2006-03-13 2012-10-09 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US8740921B2 (en) 2006-03-13 2014-06-03 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9474533B2 (en) 2006-03-13 2016-10-25 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US8142455B2 (en) 2006-03-13 2012-03-27 Pneumrx, Inc. Delivery of minimally invasive lung volume reduction devices
US10226257B2 (en) 2006-03-13 2019-03-12 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157823B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8932310B2 (en) 2006-03-13 2015-01-13 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9402632B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9402971B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US8454708B2 (en) 2006-03-31 2013-06-04 Spiration, Inc. Articulable anchor
US9198669B2 (en) 2006-03-31 2015-12-01 Spiration, Inc. Articulable anchor
US8647392B2 (en) 2006-03-31 2014-02-11 Spiration, Inc. Articulable anchor
US20070232992A1 (en) * 2006-03-31 2007-10-04 James Kutsko Articulable anchor
US20070235846A1 (en) * 2006-04-01 2007-10-11 Stats Chippac Ltd. Integrated circuit package system with net spacer
US7856979B2 (en) 2006-05-23 2010-12-28 Ventus Medical, Inc. Nasal respiratory devices
US7987852B2 (en) 2006-06-07 2011-08-02 Ventus Medical, Inc. Nasal devices
US20080041373A1 (en) * 2006-06-07 2008-02-21 Ventus Medical, Inc. Nasal devices
US8985116B2 (en) 2006-06-07 2015-03-24 Theravent, Inc. Layered nasal devices
US10639452B2 (en) 2006-07-13 2020-05-05 Best Medical International, Inc. Echo-opaque urethral catheter
US10716629B2 (en) 2006-09-15 2020-07-21 Acclarent, Inc. Methods and devices for facilitating visualization in a surgical environment
US9603506B2 (en) 2006-09-15 2017-03-28 Acclarent, Inc. Methods and devices for facilitating visualization in a surgical environment
US9179823B2 (en) 2006-09-15 2015-11-10 Acclarent, Inc. Methods and devices for facilitating visualization in a surgical environment
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US9572480B2 (en) 2006-09-15 2017-02-21 Acclarent, Inc. Methods and devices for facilitating visualization in a surgical environment
US8240309B2 (en) 2006-11-16 2012-08-14 Ventus Medical, Inc. Adjustable nasal devices
US20080178874A1 (en) * 2006-11-16 2008-07-31 Ventus Medical, Inc. Adjustable nasal devices
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080287878A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Pulmonary visceral pleura anastomosis reinforcement
US8062315B2 (en) * 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US8043301B2 (en) 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
US9326873B2 (en) 2007-10-12 2016-05-03 Spiration, Inc. Valve loader method, system, and apparatus
US8136230B2 (en) 2007-10-12 2012-03-20 Spiration, Inc. Valve loader method, system, and apparatus
US8281557B2 (en) 2007-12-05 2012-10-09 Ventus Medical, Inc. Method of packaging and dispensing nasal devices
US8020700B2 (en) 2007-12-05 2011-09-20 Ventus Medical, Inc. Packaging and dispensing nasal devices
US8453638B2 (en) 2008-02-19 2013-06-04 Portaero, Inc. One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8430094B2 (en) 2008-02-19 2013-04-30 Portaero, Inc. Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US8021320B2 (en) 2008-02-19 2011-09-20 Portaero, Inc. Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
US8252003B2 (en) 2008-02-19 2012-08-28 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US7927324B2 (en) 2008-02-19 2011-04-19 Portaero, Inc. Aspirator and method for pneumostoma management
US7909803B2 (en) 2008-02-19 2011-03-22 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8474449B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8464708B2 (en) 2008-02-19 2013-06-18 Portaero, Inc. Pneumostoma management system having a cosmetic and/or protective cover
US8506577B2 (en) 2008-02-19 2013-08-13 Portaero, Inc. Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US8231581B2 (en) 2008-02-19 2012-07-31 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8453637B2 (en) 2008-02-19 2013-06-04 Portaero, Inc. Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8348906B2 (en) 2008-02-19 2013-01-08 Portaero, Inc. Aspirator for pneumostoma management
US8347880B2 (en) 2008-02-19 2013-01-08 Potaero, Inc. Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US8365722B2 (en) 2008-02-19 2013-02-05 Portaero, Inc. Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8491602B2 (en) 2008-02-19 2013-07-23 Portaero, Inc. Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090205651A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
WO2009152107A1 (en) * 2008-06-09 2009-12-17 Allegiance Corporation Bronchoalveolar lavage catheter assembly
US20090306544A1 (en) * 2008-06-09 2009-12-10 Ho-Kin Ng Instillation/aspiration device
US20090306545A1 (en) * 2008-06-09 2009-12-10 Mamdouh Elsakka Bronchoalveolar lavage catheter assembly
CN102119039A (en) * 2008-06-09 2011-07-06 护理联合2200公司 Bronchoalveolar lavage catheter assembly
US20090301480A1 (en) * 2008-06-09 2009-12-10 Mamdouh Elsakka Diagnostic sample collection system and method of use
US20090318757A1 (en) * 2008-06-23 2009-12-24 Percuvision, Llc Flexible visually directed medical intubation instrument and method
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US10058331B2 (en) 2008-09-12 2018-08-28 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US9173669B2 (en) 2008-09-12 2015-11-03 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US9192403B2 (en) 2008-09-12 2015-11-24 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US10285707B2 (en) 2008-09-12 2019-05-14 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8721734B2 (en) 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US10076441B2 (en) 2009-06-19 2018-09-18 Braincool Ab Devices for cooling the nasal cavity
US20140350335A1 (en) * 2010-04-08 2014-11-27 Eric James Kezirian Endoscopic device and system
US8764632B2 (en) * 2010-04-08 2014-07-01 Eric James Kezirian Endoscopic device and system
US10064683B2 (en) 2010-04-08 2018-09-04 Eric James Kezirian Endoscopic device and system
US20110251457A1 (en) * 2010-04-08 2011-10-13 Eric James Kezirian Endoscopic device and system
US8875711B2 (en) 2010-05-27 2014-11-04 Theravent, Inc. Layered nasal respiratory devices
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
US20170311792A1 (en) * 2010-10-18 2017-11-02 Erhan H. Gunday Anchored Working Channel
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
US10350048B2 (en) 2011-09-23 2019-07-16 Pulmonx Corporation Implant loading device and system
US20140081252A1 (en) * 2012-09-14 2014-03-20 The Spectranetics Corporation Tissue slitting methods and systems
US9949753B2 (en) 2012-09-14 2018-04-24 The Spectranetics Corporation Tissue slitting methods and systems
US10531891B2 (en) * 2012-09-14 2020-01-14 The Spectranetics Corporation Tissue slitting methods and systems
US11596435B2 (en) 2012-09-14 2023-03-07 Specrtranetics Llc Tissue slitting methods and systems
US10368900B2 (en) 2012-09-14 2019-08-06 The Spectranetics Corporation Tissue slitting methods and systems
US9724122B2 (en) 2012-09-14 2017-08-08 The Spectranetics Corporation Expandable lead jacket
US9763692B2 (en) 2012-09-14 2017-09-19 The Spectranetics Corporation Tissue slitting methods and systems
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
US10362927B2 (en) * 2013-02-01 2019-07-30 Deka Products Limited Partnership Endoscope with pannable camera
US11925380B2 (en) 2013-03-14 2024-03-12 Spectranetics Llc Distal end supported tissue slitting apparatus
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10349977B2 (en) * 2013-03-15 2019-07-16 Sanovas Intellectual Property, Llc Resector balloon catheter with multi-port hub
US9737195B2 (en) 2013-03-15 2017-08-22 Sanovas, Inc. Handheld resector balloon system
US20140275777A1 (en) * 2013-03-15 2014-09-18 Erhan H. Gunday Resector Balloon Catheter With Multi-Port Hub
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US10624733B2 (en) 2015-03-24 2020-04-21 Spiration, Inc. Airway stent
US10098523B2 (en) * 2015-11-18 2018-10-16 Art Healthcare Ltd. Sheath and hub for imaging endoscope
US20170135560A1 (en) * 2015-11-18 2017-05-18 Art Healthcare Ltd. Sheath and hub for imaging endoscope
US10588493B2 (en) 2015-11-18 2020-03-17 Art Healthcare Ltd. Sheath and hub for imaging endoscope
CN105536081A (en) * 2016-01-22 2016-05-04 长江大学 Full-automatic body cavity effusion and pneumatosis extraction instrument
US10232107B2 (en) * 2016-03-11 2019-03-19 Hans Utz Illuminated medical infusion
US20170258983A1 (en) * 2016-03-11 2017-09-14 Hans Utz Illuminated medical infusion
CN109498966A (en) * 2019-01-11 2019-03-22 上海市肺科医院 Bronchogenic tuberculosis auxiliary therapeutic apparatus under a kind of airway wall
WO2021011408A1 (en) 2019-07-12 2021-01-21 Bard Access Systems, Inc. Tubing with integrated optical fiber, medical devices, and methods thereof
EP3996789A4 (en) * 2019-07-12 2023-08-23 Bard Access Systems, Inc. Tubing with integrated optical fiber, medical devices, and methods thereof
US11957318B2 (en) 2021-04-29 2024-04-16 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat

Also Published As

Publication number Publication date
WO2003105941A1 (en) 2003-12-24
US6398775B1 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
US6398775B1 (en) Apparatus and method for isolated lung access
US7186259B2 (en) Methods, systems, and kits for lung volume reduction
US6585639B1 (en) Sheath and method for reconfiguring lung viewing scope
US10456519B2 (en) Apparatus and method for irrigating sinus cavity
EP0691866B1 (en) Balloon catheter and device for perfusion with the balloon catheter
EP0687478A1 (en) Improved catheter system for delivery of aerosolized medicine for use with pressurized propellant canister
US8074649B2 (en) Endotracheal tube with feature for delivering aerosolized medication
KR20080033346A (en) Multilumen tracheal catheter to prevent cross contamination
CN104220015A (en) Balloon dilation catheter system for treatment and irrigation of the sinuses
BRPI0919884B1 (en) occlusion perfusion catheter
WO2001002042A9 (en) Methods, systems, and kits for lung volume reduction
US20210379302A1 (en) Medical scopes for delivering therapeutic agents
US8137302B2 (en) Methods and systems for occluding collateral flow channels in the lung
JP2000279524A (en) Catheter
US20220355024A1 (en) Agent delivery devices and methods of using the same
MX2008001811A (en) Multilumen tracheal catheter to prevent cross contamination

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: PULMONX, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PERKINS, RODNEY A.;SOLTESZ, PETER P.;KOTMEL, ROBERT;REEL/FRAME:048642/0638

Effective date: 20000331